Days At A Glance Speakers Session Type Search
Type

    08:30 - 20:00 
    Registration
    Strathblane Hall
    09:30 - 09:40 
    Welcome
    Pentland Auditorium
    Welcome
    President's Welcome to SfE BES 2021
    Oxford, United Kingdom
    09:45 - 10:15 
    What is New?
    Journal of Endocrinology
    Pentland Auditorium
    Chair: Professor Duncan Bassett (Imperial College, London, UK)
    WIN
    WIN1
    What is New?
    What is New in Basic Endocrinology Research?
    Imperial College London, London, United Kingdom
    WIN2
    What is New?
    What is New in Clinical Endocrinology Research?
    Barts Health NHS Trust, London, UK
    10:15 - 11:00 
    SfE BES 75th Anniversary Lecture
    Pentland Auditorium
    Chair: Professor Rajesh Thakker (University of Oxford, Oxford, UK)
    AN1
    SfE BES 75th Anniversary Lecture
    Discovery of a new hormone, leptin, and its roles in health and disease
    Rockefeller University, New York, USA
    11:05 - 12:35 
    How Do I...?
    Addison's Disease Self-Help Group
    Pentland Auditorium
    Chairs: Dr Annice Mukherjee (Spire Manchester Hospital, Manchester, UK) & Dr Afroze Abbas (University of Leeds, Leeds, UK)
    HDI1.1
    How Do I...?
    How should I investigate for effect of radiotherapy on the hypothalamus and pituitary?

    Unknown speaker

    The Christie NHS Foundation Trust, Manchester, UK
    HDI1.2
    How Do I...?
    How do I investigate a young person with a low trauma fracture?
    Sheffield, UK
    HDI1.3
    How Do I...?
    How do I use AMH in clinical practice?
    University College London Hospital, London, UK
    HDI1.4
    How Do I...?
    How do I screen an SDH gene carrier?

    Unknown speaker

    Cambridge University Hospital NHS Foundation Trust, Cambridge, United Kingdom
    HDI1.5
    How Do I...?
    How do I keep my patients with adrenal insufficiency safe?
    University College London Hospital, London, UK
    HDI1.6
    How Do I...?
    How do I optimise thyroid status after RAI therapy?
    Royal Infirmary of Edinburgh, Edinburgh, UK
    11:05 - 12:35 
    Clinical Management Workshop 1: Pituitary Challenges: Prompt, Practical and Post-op
    Endocrinology, Diabetes & Metabolism Case Reports
    Kilsyth & Moorfoot
    Chairs: Dr Miles Levy (University Hospitals of Leicester, Leicester, UK) & Dr Rupa Ahluwalia (Norfolk and Norwich University Hospitals NHS Trust, Norfolk, UK)
    CMW1.1
    Clinical Management Workshop 1: Pituitary Challenges: Prompt, Practical and Post-op
    Apoplexy
    Birmingham, UK
    CMW1.2
    Clinical Management Workshop 1: Pituitary Challenges: Prompt, Practical and Post-op
    Acute Cushing's
    Guy's and St Thomas' Hospital, London, UK
    CMW1.3
    Clinical Management Workshop 1: Pituitary Challenges: Prompt, Practical and Post-op
    Post op management
    John Radcliffe Hospital, Oxford, UK
    11:05 - 12:35 
    Basic Physiology Workshop 1: New Techniques and Approaches
    Journal of Endocrinology
    Sidlaw Auditorium
    Chairs: Dr Jane Howard (Kings College London, London, UK) & Miss Hannah Stephens (Imperial College London, London, UK)
    BPW1.1
    Basic Physiology Workshop 1: New Techniques and Approaches
    Applying cryo-EM to understanding the structure and dynamics of GPCRs
    Monash Institute of Pharmaceutical Sciences, Melbourne, Australia
    BPW1.2
    Basic Physiology Workshop 1: New Techniques and Approaches
    SC analysis and heterogeneity of hypothalamic neurons
    University of Cambridge, Cambridge, UK
    BPW1.3
    Basic Physiology Workshop 1: New Techniques and Approaches
    What you need to know about immunometabolism
    Dresden University of Technology, Dresden, Germany
    12:35 - 13:55 
    LUNCH, EXHIBITION, SATELLITES AND POSTERS
    Lennox Suite & Concourse
    12:45 - 13:20 
    Oral Posters 1 - Thyroid
    Cromdale Hall
    Chairs: Dr Carla Moran (Beacon Hospital, Dublin, Ireland) & Dr Anna Mitchell (Newcastle University, Newcastle, UK)
    OP1
    OP1.1
    Oral Posters 1 - Thyroid
    Factors predicting long-term outcome and the need for surgery in Graves' Orbitopathy extended follow-up from the CIRTED Trial

    Unknown speaker

    Cardiff University, Cardiff, UK
    OP1.2
    Oral Posters 1 - Thyroid
    Long-term management of thyrotoxicosis with anti-thyroid drugs (ATDs)
    Swansea Bay University Health Board, Swansea, UK
    OP1.3
    Oral Posters 1 - Thyroid
    Thyroid Endocrine Nurse Service: Improving patient experience
    Imperial College Healthcare NHS Trust, London, UK
    OP1.4
    Oral Posters 1 - Thyroid
    Autoimmune thyrotoxicosis: is first line treatment with anti-thyroid medication good enough?
    United Lincolnshire Hospitals NHS Trust, Lincoln, UK
    12:55 - 13:55 
    INDUSTRY-SPONSORED SATELLITE SYMPOSIA - (Please see Sponsored Satellite Symposia programme for more information)
    Kilsyth & Moorfoot
    12:55 - 13:55 
    INDUSTRY-SPONSORED SATELLITE SYMPOSIA - (Please see Sponsored Satellite Symposia programme for more information)
    Sidlaw Auditorium
    13:20 - 13:55 
    Oral Posters 2 - Adrenal and Cardiovascular
    Cromdale Hall
    Chairs: Dr Scott MacKenzie (University of Glasgow, Glasgow, UK) & Dr Yasir Elhassan (Queen Elizabeth Hospital Birmingham, Birmingham, UK)
    OP2
    OP2.1
    Oral Posters 2 - Adrenal and Cardiovascular
    A phase 1 clinical trial evaluating the safety and efficacy of up to two administrations of the adrenal PET tracer [18F]CETO in healthy volunteers and patients with primary aldosteronism
    University of Cambridge, Cambridge, UK
    OP2.2
    Oral Posters 2 - Adrenal and Cardiovascular
    Single-centre analysis of 900 short synacthen tests: do pre-test clinical or biochemical variables predict failure?
    Oxford Centre for Diabetes, Endocrinology and Metabolism, Oxford, UK
    OP2.3
    Oral Posters 2 - Adrenal and Cardiovascular
    PLK1 inhibitors as a new targeted treatment for adrenocortical carcinoma
    Institute of Metabolism and System Research, Birmingham, UK
    OP2.4
    Oral Posters 2 - Adrenal and Cardiovascular
    Modelling changes in the control, secretion and metabolism of cortisol during and after heart surgery.
    University of Birmingham, Birmingham, UK
    14:00 - 14:30 
    Plenary 1: British Thyroid Association Pitt-Rivers Lecture
    British Thyroid Association
    Pentland Auditorium
    Chair: Professor Simon Pearce (Newcastle University, Newcastle, UK)
    PL1
    PL1
    Plenary 1: British Thyroid Association Pitt-Rivers Lecture
    Role of thyroid hormone transporters in brain development and function
    Essen, Germany
    14:30 - 15:00 
    Plenary 2: Society for Endocrinology Starling Medal Lecture
    Society for Endocrinology
    Pentland Auditorium
    Chair: Professor Eleanor Davies (University of Glasgow, Glasgow, UK)
    PL2
    PL2
    Plenary 2: Society for Endocrinology Starling Medal Lecture
    Strategies to turn up the heat - investigating human brown adipose tissue function
    University of Edinburgh, Edinburgh, UK
    15:05 - 16:35 
    Oral Communications 1 - Reproductive and Neuroendocrinology
    Klinefelter's Syndrome Association
    Pentland Auditorium
    Chairs: Dr Bryn Owen (Imperial College London, London, UK) & Sijing Cheng (Imperial College London, London, UK)
    OC1
    OC1.1
    Oral Communications 1 - Reproductive and Neuroendocrinology
    Melanocortin-4 receptor agonism improves sexual brain processing in women with low sexual desire
    Imperial College London, London, UK
    OC1.2
    Oral Communications 1 - Reproductive and Neuroendocrinology
    Hyper-phosphorylation of β-catenin at Serine552 correlates with invasion and predicts recurrence of non-functioning pituitary tumours (NFPTs)
    Queen Mary University of London, London, UK
    OC1.3
    Oral Communications 1 - Reproductive and Neuroendocrinology
    Acromegalic cardiomyopathy in pituitary-specific aryl hydrocarbon receptor interacting protein (Aip) gene knockout animals

    Unknown speaker

    Queen Mary University of London, London, UK
    OC1.4
    Oral Communications 1 - Reproductive and Neuroendocrinology
    Intranasal kisspeptin administration stimulates reproductive hormone secretion in healthy men
    Imperial College London, London, UK
    OC1.5
    Oral Communications 1 - Reproductive and Neuroendocrinology
    Is radiotherapy for pituitary adenoma or craniopharyngioma associated with increased risk of second brain tumour? A long-term multi-centre study of 3,679 patients
    University of Birmingham, Birmingham, UK
    OC1.6
    Oral Communications 1 - Reproductive and Neuroendocrinology
    Differential follicle stimulating hormone glycosylation modulates pre-antral follicle growth and survival rates

    Unknown speaker

    King's College London, London, UK
    15:05 - 16:35 
    Oral Communications 2 - Endocrine Cancer and Late Effects
    Sidlaw Auditorium
    Chairs: Dr Paul Newey (University of Dundee, UK) & Dr Anna Mitchell (Newcastle University, Newcastle, UK)
    OC2
    OC2.1
    Oral Communications 2 - Endocrine Cancer and Late Effects
    Outcomes of surgery and treatment with selective RET TK inhibitor Selpercatinib in children with MEN2 and advanced MTC.

    Unknown speaker

    University College London Hospitals NHS Foundation Trust, London, UK
    OC2.2
    Oral Communications 2 - Endocrine Cancer and Late Effects
    An emerging role for proteostasis modulators targeting NIS activity to enhance radioiodide therapy in thyroid cancer
    University of Birmingham, Birmingham, UK
    OC2.3
    Oral Communications 2 - Endocrine Cancer and Late Effects
    A novel in vivo platform for studying tumour vascularization and endocrine responses
    Imperial College London, London, UK
    OC2.4
    Oral Communications 2 - Endocrine Cancer and Late Effects
    PBF phosphorylation regulates cell motility of thyroid and breast cancer cells
    University of Birmingham Institute of Metabolism and System Research, Birmingham, UK
    OC2.5
    Oral Communications 2 - Endocrine Cancer and Late Effects
    A novel MiR-346-directed DNA damage mechanism is regulated by its interaction with long non-coding RNA, NORAD, in prostate cancer
    Imperial College London, London, UK
    OC2.6
    Oral Communications 2 - Endocrine Cancer and Late Effects
    Transcriptomic analysis of succinate dehydrogenase subunit deleted cells to identify molecular mechanisms underlying the increased metastatic potential of SDHB-deficient tumours
    Queen Mary University of London, London, UK
    15:05 - 16:35 
    Oral Communications 3 - Metabolism, Obesity and Diabetes
    Kilsyth & Moorfoot
    Chairs: Professor Sadaf Farooqi (University of Cambridge, Cambridge, UK) & Dr Chioma Izzi-Engbeaya (Imperial College London, London, UK)
    OC3
    OC3.1
    Oral Communications 3 - Metabolism, Obesity and Diabetes
    The serotonin transporter SLC6A4 protects human brown adipose tissue from serotonin-mediated suppression of thermogenesis
    University of Edinburgh, Edinburgh, UK
    OC3.2
    Oral Communications 3 - Metabolism, Obesity and Diabetes
    Comparing the transcriptional landscape between lean and obese mice within the small intestinal segments
    King's College London, London, UK
    OC3.3
    Oral Communications 3 - Metabolism, Obesity and Diabetes
    Sex-specific risk of obesity and cardiometabolic disease in low- and middle-income countries (LMICs): a meta-analysis in 681929 individuals
    MRC Laboratory of Medical Sciences and Imperial College London, Birmingham, UK
    OC3.4
    Oral Communications 3 - Metabolism, Obesity and Diabetes
    Hepatic choline deficiency underpins amelioration of visceral obesity and diabetes in ectonucleotide pyrophosphatase (Enpp)-6–/–mice
    University of Edinburgh, Edinburgh, UK
    OC3.5
    Oral Communications 3 - Metabolism, Obesity and Diabetes
    Microbial tryptophan metabolites modulate L-cell-induced GLP-1 secretion to improve glucose homeostasis
    Imperial College London, London, UK
    OC3.6
    Oral Communications 3 - Metabolism, Obesity and Diabetes
    Stimulation of motilin secretion by bile, free fatty acids and acidification in human duodenal organoids
    Wellcome Trust, Cambridge, UK
    16:35 - 17:00 
    TEA & COFFEE
    Lennox Suite
    17:00 - 17:45 
    Presidential Lecture
    Society for Endocrinology
    Pentland Auditorium
    Chair: Professor Rajesh Thakker (University of Oxford, Oxford, UK)
    PR1
    Presidential Lecture
    Elucidation of cellular oxygen sensing mechanisms: implications for medicine
    Nuffield Department of Medicine, Oxford, UK
    17:45 - 18:15 
    Plenary 3: Society for Endocrinology Dale Medal Lecture
    Society for Endocrinology
    Pentland Auditorium
    Chair: Professor Mark Gurnell (University of Cambridge, Cambridge, UK)
    PL3
    PL3
    Plenary 3: Society for Endocrinology Dale Medal Lecture
    The biology of weight regulation
    MRC Institute of Metabolic Science, Cambridge, UK
    18:15 - 19:00 
    Debate: TO BLOCK, OR NOT TO BLOCK, THAT IS THE QUESTION: Controversies in peri-operative management of catecholamine producing tumours
    Motion: This house believes that α-blockade is essential for phaeochromocytoma surgery
    Endocrine-Related Cancer
    Pentland Auditorium
    Chair: Dr Ruth Casey (Cambridge University Hospital NHS Foundation Trust, Cambridge, UK)
    D1
    D1.1
    Debate: TO BLOCK, OR NOT TO BLOCK, THAT IS THE QUESTION: Controversies in peri-operative management of catecholamine producing tumours
    For the motion
    St Bartholomew’s Hospital, London, UK
    D1.2
    Debate: TO BLOCK, OR NOT TO BLOCK, THAT IS THE QUESTION: Controversies in peri-operative management of catecholamine producing tumours
    Against the motion
    University of Duidburg-Essen, Essen, Germany
    19:00 - 20:30 
    Presidential Welcome Reception
    Lennox Suite
    19:30 - 22:00 
    Early Career Dinner & Quiz
    Cromdale Hall

    07:00 - 20:00 
    Registration
    Strathblane Hall
    07:40 - 08:20 
    The New SfE Androgen Replacement Guidelines
    Pentland Auditorium
    Chairs: Dr Richard Quinton (Newcastle University, Newcastle, UK) & Dr Channa Jayasena (Imperial College London, London, UK)
    ARG1.1
    The New SfE Androgen Replacement Guidelines
    Androgen replacement in men: Classification, diagnosis and biochemical assessment
    Imperial College London, London, UK
    ARG1.2
    The New SfE Androgen Replacement Guidelines
    Changes to safety monitoring for androgen replacement in men
    Imperial College London, London, UK
    08:30 - 09:00 
    Plenary 4: Society for Endocrinology Transatlantic Medal Lecture
    Society for Endocrinology
    Pentland Auditorium
    Chair: Professor Duncan Bassett (Imperial College London, London, UK)
    PL4
    PL4
    Plenary 4: Society for Endocrinology Transatlantic Medal Lecture
    Feast and famine: nuclear receptor control of liver energy balance
    University of California, California, USA
    09:00 - 09:30 
    Plenary 5: Society for Endocrinology International Medal Lecture
    Society for Endocrinology
    Pentland Auditorium
    Chair: Professor Robert Semple (University of Edinburgh, Edinburgh, UK)
    PL5
    PL5
    Plenary 5: Society for Endocrinology International Medal Lecture
    Activation of the gp130 receptor: a panacea for the treatment of metabolic diseases?
    Monash University, Melbourne, Australia
    09:35 - 10:35 
    Early Careers and Plenary Orals
    Clinical Endocrinology Trust
    Pentland Auditorium
    Chairs: Professor Maralyn Druce (Barts Health NHS Trust, London, UK) & Professor Kevin Murphy (Imperial College London, London, UK) & Dr Helen Turner (Oxford University Hospitals NHS Foundation Trust, Oxford, UK)
    EC1.1
    Early Careers and Plenary Orals
    Early Career Prize Lecture Basic Science: Using gene discovery to identify new key regulators of beta cell development
    University of Exeter, Exeter, UK
    EC1.2
    Early Careers and Plenary Orals
    Early Career Prize Lecture Clinical: Cardiometabolic disease burden and urine steroid metabolome in benign adrenocortical tumours: a case-control study
    University of Birmingham, Birmingham, UK
    EC1.3
    Early Careers and Plenary Orals
    CET Best Clinical Abstract: Phase 3 and extension study of modified-release hydrocortisone in the treatment of congenital adrenal hyperplasia
    Diurnal Ltd, Cardiff, United Kingdom
    Diurnal Ltd, Sheffield, UK
    EC1.4
    Early Careers and Plenary Orals
    CET Best Basic Abstract: The vagal calcium sensing receptor mediates the effect of protein ingestion on insulin release and regulates macronutrient metabolism
    Imperial College London, London, UK
    10:35 - 10:55 
    TEA & COFFEE
    Lennox Suite
    11:00 - 11:30 
    Teaching Achievement Award
    Pentland Auditorium
    Chair: Professor Eleanor Davies (University of Glasgow, Glasgow, UK)
    TAA1
    Teaching Achievement Award
    Teaching fertile minds- seeking out teaching opportunities during clinical training
    Imperial College London, London, UK
    TAA2
    Teaching Achievement Award
    Developing a Career in Education
    Imperial College London, London, UK
    11:00 - 11:30 
    Outstanding Clinical Practitioners Award
    Sidlaw Auditorium
    Chairs: Dr Paul Carroll (Guy's & St. Thomas' NHS Foundation Trust, London, UK)
    OCP1.1
    Outstanding Clinical Practitioners Award
    Improving the care of patients with thyroid diseases
    University of Birmingham, Birmingham, UK
    OCP1.2
    Outstanding Clinical Practitioners Award
    Patient safety - Shifting the paradigm
    University College London Hospital, London, UK
    11:00 - 11:30 
    Endocrine Nurse Award & Nikki Kieffer Medal
    Tinto
    Chair: Phillip Yeoh (The London Clinic, London, UK)
    ENA1
    Endocrine Nurse Award & Nikki Kieffer Medal
    Endocrine Nurse Award 2020
    University Hospitals Birmingham, Birmingham, UK
    NKM1
    Endocrine Nurse Award & Nikki Kieffer Medal
    Nikki Kieffer Medal
    Oxford Centre for Diabetes, Endocrinology and Metabolism, Oxford, UK
    11:30 - 13:00 
    Symposium 1: Lifestyle Hacks for Metabolic Disease
    Endocrine Connections
    Kilsyth & Moorfoot
    Chairs: Professor Barbara McGowan (St Thomas’s Hospital, London, UK) & Dr Chioma Izzi-Engbeaya (Imperial College London, London, UK)
    S1.1
    Symposium 1: Lifestyle Hacks for Metabolic Disease
    When not to eat; from mice to men
    University of Utah, Utah, USA
    S1.2
    Symposium 1: Lifestyle Hacks for Metabolic Disease
    Remission possible, curing diabetes?
    Newcastle University, Newcastle, UK
    S1.3
    Symposium 1: Lifestyle Hacks for Metabolic Disease
    A new era in gut-hormone based pharmacotherapy for people with obesity?
    University College London, London, UK
    11:30 - 13:00 
    Symposium 2: Nuclear Receptors in Male Reproduction
    Journal of Molecular Endocrinology
    Pentland Auditorium
    Chairs: Dr Douglas Gibson (University of Edinburgh, UK) & Dr Kim Jonas (King's College London, London, UK)
    S2.1
    Symposium 2: Nuclear Receptors in Male Reproduction
    LXR and testicular function
    Imperial College London, London, UK
    S2.2
    Symposium 2: Nuclear Receptors in Male Reproduction
    Bile acid metabolism & nuclear receptors in male reproduction
    GReD, Clermont-Ferrand, France
    S2.3
    Symposium 2: Nuclear Receptors in Male Reproduction
    Rapid gene therapy targeting of nuclear receptor pathways in the testis
    University of Newcastle, New South Wales, Australia
    11:30 - 13:00 
    Symposium 3: Novel Approaches to the Diagnosis and Treatment of Endocrine Neoplasia
    AMEND
    Sidlaw Auditorium
    Chairs: Dr Kate Lines (Oxford University, Oxford, UK) & Dr Claire Fletcher (Imperial College London, London, UK)
    S3.1
    Symposium 3: Novel Approaches to the Diagnosis and Treatment of Endocrine Neoplasia
    Diagnosis and management of MEN1 in childhood and adolescence
    University of Oxford, Oxford, UK
    S3.2
    Symposium 3: Novel Approaches to the Diagnosis and Treatment of Endocrine Neoplasia
    Advances in diagnostics for ACC-a multiomics approach
    MRC Laboratory of Medical Sciences, London, UK
    S3.3
    Symposium 3: Novel Approaches to the Diagnosis and Treatment of Endocrine Neoplasia
    Discussion
    University of Oxford, Oxford, UK
    Imperial College London, London, UK
    University of Oxford, Oxford, UK

    Unknown speaker

    University of Oxford, Oxford, UK
    Imperial College London, London, UK
    University of Oxford, Oxford, UK
    MRC Laboratory of Medical Sciences, London, UK
    11:30 - 13:00 
    Nurses' Session 1: Acromegaly
    The Pituitary Foundation
    Tinto
    Chairs: Sherwin Criseno (University Hospitals Birmingham, Birmingham, UK) & Aldons Chua (East Sussex Healthcare NHS Trust, East Sussex, UK)
    NS1
    NS1.1
    Nurses' Session 1: Acromegaly
    Advances in the management of Acromegaly 2021
    St James’s Hospital, Leeds, UK
    NS1.2
    Nurses' Session 1: Acromegaly
    Biochemical cure – is this enough?
    Birmingham, UK
    NS1.3
    Nurses' Session 1: Acromegaly
    Addressing the unmet psychosocial needs of patients with treated Acromegaly
    The Pituitary Foundation, Bristol, UK
    13:05 - 13:50 
    Meet the Expert 1 (Adrenal and Cardiovascular)
    Pentland Auditorium
    Chair: Dr Yasir Elhassan (University of Birmingham, Birmingham, UK)
    MTE1
    Meet the Expert 1 (Adrenal and Cardiovascular)
    Preconception in pregnancy care in CAH
    Munich, Germany
    13:05 - 13:50 
    Meet the Expert 2 (Bone and Calcium)
    Kilsyth & Moorfoot
    Chair: Dr Jennifer Walsh (The University of Sheffield, Sheffield, UK)
    MTE2
    Meet the Expert 2 (Bone and Calcium)
    Measuring bone markers
    Northern General Hospital, Sheffield, UK
    13:05 - 13:50 
    Meet the Expert 3 (Thyroid)
    British Thyroid Foundation
    Sidlaw Auditorium
    Chair: Dr Nicola Zammitt (Edinburgh Centre for Endocrinology and Diabetes, Edinburgh, UK)
    MTE3
    Meet the Expert 3 (Thyroid)
    Thyroid disease assessment and management; controversies in the NICE guidelines
    University of Birmingham, Birmingham, UK
    13:05 - 13:50 
    Meet the Expert 7 (Nurse)
    Tinto
    Chair: Lisa Shepherd (Birmingham Heartlands Hospital, Birmingham, UK)
    MTE7.1
    Meet the Expert 7 (Nurse)
    Hydrocortisone pump - Innovative practice across both NHS and Independent sector
    The London Clinic, London, UK
    MTE7.2
    Meet the Expert 7 (Nurse)
    How adolescent care is different to adults or children
    Guy's and St. Thomas' NHS Foundation Trust, London, UK
    13:50 - 15:05 
    LUNCH, EXHIBITION, SATELLITES AND POSTERS
    Lennox Suite & Concourse
    13:55 - 14:30 
    Oral Posters 3 - Reproductive and Neuroendocrinology
    Cromdale Hall
    Chairs: Tatiana Lopes (Imperial College London, London, UK) & Dr Ali Abbara (Imperial College London, London, UK)
    OP3
    OP3.1
    Oral Posters 3 - Reproductive and Neuroendocrinology
    Discordant growth hormone and insulin like growth factor-1 values are associated with an increased mortality over concordant normal values in patients treated for acromegaly
    Medical University of Gdansk, Gdansk, Poland
    OP3.2
    Oral Posters 3 - Reproductive and Neuroendocrinology
    An ex-vivo human placental model demonstrates that temporal fluctuations in maternal glucose in gestational diabetes alter placental transcriptome networks associated vascular development and angiogenesis
    University of Leeds, Leeds, UK
    OP3.3
    Oral Posters 3 - Reproductive and Neuroendocrinology
    ‘Suppression imaging’ – a novel PET technique for increasing confidence in the localisation of secretory pituitary microadenomas
    University of Cambridge and Cambridge University Hospitals, Cambridge, UK
    OP3.4
    Oral Posters 3 - Reproductive and Neuroendocrinology
    Stem cell heterogeneity and regulation in the postnatal pituitary gland
    King's College London, London, UK
    14:05 - 15:05 
    INDUSTRY-SPONSORED SATELLITE SYMPOSIA - (Please see Sponsored Satellite Symposia programme for more information)
    Kilsyth & Moorfoot
    14:05 - 15:05 
    INDUSTRY-SPONSORED SATELLITE SYMPOSIA - (Please see Sponsored Satellite Symposia programme for more information)
    Sidlaw Auditorium
    14:30 - 15:05 
    Oral Posters 4 - Metabolism, Obesity and Diabetes
    Cromdale Hall
    Chairs: Dr Abd Tahrani (University of Birmingham, Birmingham, UK) & Dr Patricia Thomas (University of Birmingham, Birmingham, UK)
    OP4
    OP4.1
    Oral Posters 4 - Metabolism, Obesity and Diabetes
    Investigating the role of the gut metabolome in appetite and obesity
    Imperial College London, London, UK
    OP4.2
    Oral Posters 4 - Metabolism, Obesity and Diabetes
    3mg Liraglutide ameliorates inflammation and improves hypothalamic regulation of energy homeostasis by modulation of Sphingosine-1-Phosphate signalling in super-responders
    University of Derby, Derby, United Kingdom
    OP4.3
    Oral Posters 4 - Metabolism, Obesity and Diabetes
    The Chemerin-CMKLR1 Axis is Functionally Important for Central Regulation of Energy Homeostasis
    Nottingham Trent University, Nottingham, UK
    OP4.4
    Oral Posters 4 - Metabolism, Obesity and Diabetes
    Audit of Clinical Outcomes with Dexamethasone in Patients Hospitalised with COVID-19
    Imperial College London, London, UK
    15:10 - 16:40 
    Oral Communications 4 - Adrenal and Cardiovascular
    Pentland Auditorium
    Chairs: Dr Cristina Ronchi (University of Birmingham, Birmingham, UK) & Dr Scott MacKenzie (University of Glasgow, Glasgow, UK)
    OC4
    OC4.1
    Oral Communications 4 - Adrenal and Cardiovascular
    Development of [18F]AldoView as the first highly selective aldosterone synthase PET tracer for imaging of patients with Primary Hyperaldosteronism.
    University College London, London, UK
    OC4.2
    Oral Communications 4 - Adrenal and Cardiovascular
    Somatic mutations of GNA11 and GNAQ in CTNNB1-mutant aldosterone-producing adenomas presenting in puberty, pregnancy or menopause.
    Queen Mary University London, London, UK
    OC4.3
    Oral Communications 4 - Adrenal and Cardiovascular
    [11C]Metomidate PET/CT can aid decision-making in patients with primary aldosteronism
    University of Cambridge, Cambridge, UK
    OC4.4
    Oral Communications 4 - Adrenal and Cardiovascular
    24-hour dynamics of free tissue adrenal hormones: A description of healthy normal variation
    University of Bristol, Bristol, UK
    OC4.5
    Oral Communications 4 - Adrenal and Cardiovascular
    Circulating cell-free DNA-based biomarkers as a tool for disease surveillance in adrenocortical carcinoma
    Institute of Metabolism and System Research, Birmingham, UK
    OC4.6
    Oral Communications 4 - Adrenal and Cardiovascular
    Glucocorticoids and the Vascular Molecular Clock : Implications in Vascular Function Control
    Centre for Cardiovascular Science, Edinburgh, United Kingdom
    15:10 - 16:40 
    Oral Communications 5 - Bone and Calcium
    Kilsyth & Moorfoot
    Chairs: Dr Zaki Hassan-Smith (University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK) & Dr Claire Higham (The Christie NHS Foundation Trust, Manchester, UK)
    OC5
    OC5.1
    Oral Communications 5 - Bone and Calcium
    Successful adeno-associated virus mediated neonatal gene therapy treatment of hypophosphatasia murine model resulted in bone maturation and increased survival to at least 18 months
    Nippon Medical School, Tokyo, Japan
    OC5.2
    Oral Communications 5 - Bone and Calcium
    Gastric inhibitory polypeptide (GIP) reduces human osteoclast activity by suppressing multiple signalling pathways
    Odense University Hospital, Odense, Denmark
    OC5.3
    Oral Communications 5 - Bone and Calcium
    Role of Intact and C-Terminal FGF-23 Assays in the Investigation of Metabolic Bone Disease.
    Norfolk and Norwich University Hospitals NHS Foundation Trust, Norwich, UK
    OC5.4
    Oral Communications 5 - Bone and Calcium
    Nuclear factor I/X (NFIX) regulates the transcriptional activity of the cellular retinoic acid binding protein 2 (CRABP2) promoter and altersCRABP2 expression in Marshall-Smith Syndrome (MSS) patients.
    University of Oxford, Oxford, UK
    OC5.5
    Oral Communications 5 - Bone and Calcium
    Diacylglycerol kinase delta haploinsufficiency in mice causes hypocalcaemia: relevance to human Autosomal Dominant Hypoclacemia (ADH)
    University of Oxford, Oxford, UK
    OC5.6
    Oral Communications 5 - Bone and Calcium
    The role of vitamin D supplementation in critically ill patients with COVID-19
    Newcastle University, Newcastle, UK
    15:10 - 16:40 
    Oral Communications 6 - Thyroid
    Sidlaw Auditorium
    Chairs: Professor Bijay Vaidya (Royal Devon and Exeter Hospital, Exeter, UK) & Dr Peter Taylor (Cardiff University, Cardiff, UK)
    OC6
    OC6.1
    Oral Communications 6 - Thyroid
    Adjuvant Rituximab – exploratory trial in young people with Graves’ disease
    Newcastle, UK
    OC6.2
    Oral Communications 6 - Thyroid
    Concerted action of TH transporters MCT8 and OATP1C1 regulates adult hippocampal neurogenesis and hippocampal function in mice
    University of Duisburg-Essen, Essen, Germany
    OC6.3
    Oral Communications 6 - Thyroid
    Failure of Radioiodine Remnant Ablation to Improve Postoperative Outcome in 2668 Adult Patients with AJCC/pTNM stage I Papillary Thyroid Carcinoma
    Mayo Clinic, Rochester, MN, USA
    OC6.4
    Oral Communications 6 - Thyroid
    AP-2 and Moesin Regulate the Internalisation of the Sodium-Iodide Symporter and Affect I125 Uptake in Thyroid Cancer Cells.
    University of Birmingham, Birmingham, UK
    OC6.5
    Oral Communications 6 - Thyroid
    Effects of in utero thyroid hormone exposure on human neurodevelopment: MRI analysis from the Controlled Antenatal Thyroid Screening Study
    Cardiff University, Cardiff, UK
    OC6.6
    Oral Communications 6 - Thyroid
    Forty years' experience of national screening programme for congenital hypothyroidism in Northern Ireland.
    Queen's University Belfast, Belfast, UK
    Royal Victoria Hospital, Belfast, UK
    15:10 - 16:40 
    Nurses' Session 2: Career Pathways in Endocrine Nursing: Entry points and Academic progression
    Neuroendocrine Cancer UK
    Tinto
    Chairs: Anne Marland (Oxford Centre for Diabetes, Endocrinology and Metabolism, Oxford, UK) & Kathryn Kinsella (Salford Royal NHS Foundation Trust, Salford, UK)
    NS2
    NS2.1
    Nurses' Session 2: Career Pathways in Endocrine Nursing: Entry points and Academic progression
    Advanced Practice and Prescribing
    UK
    NS2.2
    Nurses' Session 2: Career Pathways in Endocrine Nursing: Entry points and Academic progression
    Graduate Experience – Masters Module in Endocrine Nursing
    University of Oxford Hospitals, Oxford, UK
    NS2.3
    Nurses' Session 2: Career Pathways in Endocrine Nursing: Entry points and Academic progression
    An NIHR Fellowship
    University of Birmingham, Birmingham, UK
    NS2.4
    Nurses' Session 2: Career Pathways in Endocrine Nursing: Entry points and Academic progression
    Discussion
    Oxford Centre for Diabetes, Endocrinology and Metabolism, Oxford, UK
    Salford Royal NHS Foundation Trust, Salford, UK
    London South Bank University, London, UK
    University of Oxford Hospitals, Oxford, UK
    University of Birmingham, Birmingham, UK
    16:40 - 17:10 
    TEA & COFFEE
    Lennox Suite
    17:10 - 18:40 
    How Do I...? 2
    Pentland Auditorium
    Chairs: Dr Antonia Brooke (Royal Devon and Exeter Hospital, Exeter, UK) & Dr Azmi Mohammed (County Durham and Darlington NHS Foundation Trust, UK)
    HDI2.1
    How Do I...? 2
    How do I investigate abnormal alkaline phosphatase and bone context?
    St Vincent's University Hospital, Dublin, Ireland
    HDI2.2
    How Do I...? 2
    How do I diagnose and manage a low testosterone in men with obesity?
    Imperial College London, London, UK
    HDI2.3
    How Do I...? 2
    How do I manage pituitary macroadenoma in pregnancy?
    The University of Edinburgh, Edinburgh, UK
    HDI2.4
    How Do I...? 2
    How do I screen for cardiovascular effects of cancer treatments?
    University College London Hospital, London, UK
    HDI2.5
    How Do I...? 2
    How do I confirm biochemical diagnosis of primary aldosteronism?
    Queen Elizabeth University Hospital, Glasgow, UK
    HDI2.6
    How Do I...? 2
    How do I approach isolated hypothyroxinaemia?
    Beacon Hospital and University College Dublin, Dublin, Ireland
    17:10 - 18:40 
    Basic Physiology Workshop 2: Model Systems
    Sidlaw Auditorium
    Chairs: Dr Andrew Childs (Imperial College London, London, UK) & Anastasia Tsakmaki (King’s College, London, UK)
    BPW2.1
    Basic Physiology Workshop 2: Model Systems
    Modelling diabetes using iPSCs and adult derived organoids
    King's College London, London, UK
    BPW2.2
    Basic Physiology Workshop 2: Model Systems
    Ready Player One? 3D Gut endocrinology in a dish
    King's College London, London, UK
    BPW2.3
    Basic Physiology Workshop 2: Model Systems
    Organ on a Chip
    Université de Genève, Brussels, Belgium
    17:10 - 18:40 
    Senior Endocrinologists' Session
    Kilsyth & Moorfoot
    Chairs: Dr Ian Mason (The University of Edinburgh, Edinburgh, UK) & Professor Adrian Clark (St Bartholomew's Hospital, London, UK)
    SE1.1
    Senior Endocrinologists' Session
    Are gonadotrophins more than gonadotrophins?
    Imperial College London, London, UK
    SE1.2
    Senior Endocrinologists' Session
    What in the World is EIS?
    National Institute of Environmental Health Sciences, Durham, USA
    SE1.3
    Senior Endocrinologists' Session
    INSL3: a new index of testis function in puberty and aging
    University of Nottingham, Nottingham , UK
    17:10 - 18:40 
    Nurses' Session 3: Management of Endocrine Conditions in the time of COVID
    Tinto
    Chairs: Miriam Asia (University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK) & Allan Davasgaium (University Hospitals Coventry & Warwickshire NHS Trust, Coventry, UK)
    NS3.1
    Nurses' Session 3: Management of Endocrine Conditions in the time of COVID
    Management of Hyponatraemia and Diabetes Insipidus
    University College London Hospital, London, UK
    NS3.2
    Nurses' Session 3: Management of Endocrine Conditions in the time of COVID
    Management of adrenal insufficiency
    University Hospitals Birmingham, Birmingham, UK
    NS3.3
    Nurses' Session 3: Management of Endocrine Conditions in the time of COVID
    Management of hyper- and hypo-thyroidism
    University College London Hospital, London, UK
    NS3.4
    Nurses' Session 3: Management of Endocrine Conditions in the time of COVID
    Management of pituitary tumours
    University Hospitals Birmingham, Birmingham, UK
    NS3.5
    Nurses' Session 3: Management of Endocrine Conditions in the time of COVID
    Management of calcium disorders and osteoporosis
    University Hospitals Birmingham, Birmingham, UK
    NS3.6
    Nurses' Session 3: Management of Endocrine Conditions in the time of COVID
    Management of Cushing’s syndrome
    University College London Hospital, London, UK
    18:45 - 19:15 
    Plenary 6: Society for Endocrinology European Medal Lecture
    Pentland Auditorium
    Chair: Professor Eleanor Davies (University of Glasgow, Glasgow, UK)
    PL6
    PL6
    Plenary 6: Society for Endocrinology European Medal Lecture
    Rethinking critical illness-induced corticosteroid insufficiency
    Leuven University, Leuven, Belgium
    19:15 - 20:00 
    Society for Endocrinology AGM - members only
    Pentland Auditorium
    20:00 - 00:00 
    Conference Dinner
    National Museum of Scotland

    07:30 - 17:30 
    Registration
    Strathblane Hall
    08:30 - 09:00 
    Plenary 7: Clinical Endocrinology Trust Lecture
    Clinical Endocrinology Trust
    Pentland Auditorium
    Chair: Professor Aled Rees (Cardiff University, Cardiff, UK)
    PL7
    PL7
    Plenary 7: Clinical Endocrinology Trust Lecture
    The yin and yang of hormones and glucose

    Unknown speaker

    London, London, UK
    09:00 - 09:30 
    Plenary 8: CET Visiting Professor Lecture
    Clinical Endocrinology Trust
    Pentland Auditorium
    Chair: Professor Maralyn Druce (Barts Health NHS Trust, London, UK)
    PL8
    PL8
    Plenary 8: CET Visiting Professor Lecture
    Enigma of the Adrenal SHH Progenitor
    University of Michigan, Michigan, USA
    09:35 - 10:20 
    Defining the Future of Endocrinology: SfE Recommendations for Endocrine Services and Training in the Post-COVID NHS
    Pentland Auditorium
    Chairs: Professor John Newell-Price (University of Sheffield, Sheffield, UK) & Professor Kristien Boelaert (University of Birmingham, Birmingham, UK)
    FOE1.1
    Defining the Future of Endocrinology: SfE Recommendations for Endocrine Services and Training in the Post-COVID NHS
    Introduction
    University of Sheffield, Sheffield, UK
    University of Birmingham, Birmingham, UK
    FOE1.2
    Defining the Future of Endocrinology: SfE Recommendations for Endocrine Services and Training in the Post-COVID NHS
    The Primary-Secondary Care Interface
    Leighton Hospital, Cheshire, UK
    Mid Cheshire Hospitals NHS Foundation Trust
    FOE1.3
    Defining the Future of Endocrinology: SfE Recommendations for Endocrine Services and Training in the Post-COVID NHS
    Enhancing and Protecting Training
    Homerton University Hospital, London, UK
    FOE1.4
    Defining the Future of Endocrinology: SfE Recommendations for Endocrine Services and Training in the Post-COVID NHS
    The Society for Endocrinology Resource Hub
    Homerton University Hospital, London, UK
    FOE1.5
    Defining the Future of Endocrinology: SfE Recommendations for Endocrine Services and Training in the Post-COVID NHS
    Q&A
    Leighton Hospital, Cheshire, UK
    Homerton University Hospital, London, UK
    Homerton University Hospital, London, UK
    University of Sheffield, Sheffield, UK

    Unknown speaker

    Leighton Hospital, Cheshire, UK
    Homerton University Hospital, London, UK
    Homerton University Hospital, London, UK
    University of Sheffield, Sheffield, UK
    University of Birmingham, Birmingham, UK
    Mid Cheshire Hospitals NHS Foundation Trust
    Homerton University Hospital, London, UK
    Homerton University Hospital, London, UK
    University of Sheffield, Sheffield, UK
    09:35 - 10:20 
    Clinical Skills: Genetics for the Endocrinologist
    Kilsyth & Moorfoot
    Chairs: Dr Miles Levy (The University Hospital of Leicester, Leicester, UK) & Dr Sinéad McGlacken-Byrne (UCL Great Ormond Street Institute of Child Health, London, UK)
    SK1.1
    Clinical Skills: Genetics for the Endocrinologist
    The Geneticist's Perspective
    Department of Clinical Genetics, Guy's and St Thomas' NHS Foundation Trust, London , UK
    SK1.2
    Clinical Skills: Genetics for the Endocrinologist
    The Endocrinologist's Perspective
    University of Dundee, Dundee, United Kingdom
    09:35 - 10:20 
    Basic Skills: Grants and Teaching
    Sidlaw Auditorium
    Chairs: Dr Karen Forbes (University of Leeds, Leeds, UK) & Mariana Norton (Imperial College London, London, UK)
    SK2.1
    Basic Skills: Grants and Teaching
    Grants
    University of Aberdeen, Aberdeen, UK
    SK2.2
    Basic Skills: Grants and Teaching
    Teaching
    Imperial College London, London, UK
    10:20 - 10:35 
    TEA & COFFEE
    Lennox Suite
    10:35 - 12:05 
    Symposium 4: Understanding Pathogenesis: Development of Novel Treatments
    Sidlaw Auditorium
    Chairs: Dr Colin Dayan (Cardiff University, Cardiff, UK) & Dr Catherine Napier (Newcastle University, Newcastle, UK)
    S4.1
    Symposium 4: Understanding Pathogenesis: Development of Novel Treatments
    Graves' disease
    Newcastle University, Newcastle, UK
    S4.2
    Symposium 4: Understanding Pathogenesis: Development of Novel Treatments
    Thyroid Eye Disease
    Johannes Gutenberg University Medical Center, Mianz, Germany
    S4.3
    Symposium 4: Understanding Pathogenesis: Development of Novel Treatments
    Translational Studies in Thyroid Hormone Transport
    Erasmus Medical Center, Rotterdam, The Netherlands
    10:35 - 12:05 
    Symposium 5: What is New in Calcium and Bone
    Journal of Molecular Endocrinology
    Kilsyth & Moorfoot
    Chairs: Dr Caroline Gorvin (University of Birmingham, Birmingham, UK) & Dr Rachel Crowley (St Vincent’s Private Hospital, Dublin, Ireland)
    S5.1
    Symposium 5: What is New in Calcium and Bone
    Osteomorphs: a newcell entity regulating bone resorption
    Garvan Institute of Medical Research, Sydney, Australia
    S5.2
    Symposium 5: What is New in Calcium and Bone
    Location Bias in cAMP and PTHR Biology
    University of Pittsburgh, Pittsburgh, USA
    S5.3
    Symposium 5: What is New in Calcium and Bone
    Targeting the Calcium-Sensing Receptor
    National Institute of Dental and Craniofacial Research, Bethesda MD, USA
    10:35 - 12:05 
    Symposium 6: Characterizing the Cortex to Improve Clinical Care
    Pentland Auditorium
    Chairs: Dr Russell Senanayake (University of Cambridge, Cambridge, UK) & Dr Miguel De Bono (Sheffield Teaching Hospitals, Sheffield, UK)
    S6.1
    Symposium 6: Characterizing the Cortex to Improve Clinical Care
    Single cell sequencing: lessons for the pathogenesis of adrenocortical tumours

    Unknown speaker

    University of Birmingham, Birmingham, United Kingdom
    S6.2
    Symposium 6: Characterizing the Cortex to Improve Clinical Care
    Hereditary Hyperaldosteronism

    Unknown speaker

    Université Paris Cité, Paris , France
    S6.3
    Symposium 6: Characterizing the Cortex to Improve Clinical Care
    CT characteristics of adrenal nodules to guide management
    Mayo Clinic, Minnesota, USA
    12:10 - 12:55 
    Meet the Expert 4 (Endocrine Cancer and Late Effects)
    Probe or Palpate? What is the Optimum Long Term Thyroid Surveillance in Cancer Survivors?
    Sidlaw Auditorium
    Chair: Dr Helen Simpson (University College London Hospital, London, UK)
    MTE4
    Meet the Expert 4 (Endocrine Cancer and Late Effects)
    Thyroid surveillance after radiotherapy
    Memorial Sloane Kettering Cancer center, New York, USA
    12:10 - 12:55 
    Meet the Expert 5 (Reproductive and Neuroendocrinology)
    Pentland Auditorium
    Chair: Dr Annice Mukherjee (Spire Manchester Hospital, Manchester, UK)
    MTE5
    Meet the Expert 5 (Reproductive and Neuroendocrinology)
    I want KNDy: What's New in Flushing and Fertility?
    London, UK
    12:10 - 12:55 
    Meet the Expert 6 (Metabolism, Obesity and Diabetes)
    Klinefelter's Syndrome Association
    Kilsyth & Moorfoot
    Chair: Professor Jeremy Tomlinson (University of Oxford, Oxford, UK)
    MTE6
    Meet the Expert 6 (Metabolism, Obesity and Diabetes)
    Primary interventions in obesity and weight management
    University of Birmingham, Birmingham, UK
    12:55 - 14:05 
    LUNCH, EXHIBITION, SATELLITES AND POSTERS
    Lennox Suite
    12:55 - 13:30 
    Oral Posters 5 - Bone and Calcium
    Cromdale Hall
    Chairs: Professor Rachel Crowley (St Vincent's University Hospital, Dublin, Ireland) & Dr Rowan Hardy (University of Birmingham, Birmingham, UK)
    OP5
    OP5.1
    Oral Posters 5 - Bone and Calcium
    Parathyroid hormone (PTH) of 1.6 pmol/L or more at 6 months is associated with delayed recovery of parathyroid function in post-surgical hypoparathyroidism (PoSH)
    University of Sheffield, Sheffield, UK
    OP5.2
    Oral Posters 5 - Bone and Calcium
    Society for Endocrinology / Parathyroid UK National Hypoparathyroidism Management Audit
    Norfolk and Norwich University Hospital, Norwich, UK
    OP5.3
    Oral Posters 5 - Bone and Calcium
    Vitamin D deficiency is highly prevalent among patients who died from COVID-19 in the North-East of England.
    University of Newcastle, Newcastle, UK
    OP5.4
    Oral Posters 5 - Bone and Calcium
    Normocalcaemic hyperparathyroidism: Impact of assay and reference range differences on the diagnosis
    The Royal Wolverhampton NHS Trust, Wolverhampton, UK
    13:05 - 14:05 
    INDUSTRY-SPONSORED SATELLITE SYMPOSIA - (Please see Sponsored Satellite Symposia programme for more information)
    Kilsyth & Moorfoot
    13:05 - 14:05 
    INDUSTRY-SPONSORED SATELLITE SYMPOSIA - (Please see Sponsored Satellite Symposia programme for more information)
    Sidlaw Auditorium
    13:30 - 14:05 
    Oral Posters 6 - Endocrine Cancer and Late Effects
    Cromdale Hall
    Chair: Dr Safwaan Adam (The Christie Hospital, Manchester, UK) and Dr Ahmed Al-Qaissi (Leeds Teaching Hospitals NHS Trust, Leeds, UK)
    OP6
    OP6.1
    Oral Posters 6 - Endocrine Cancer and Late Effects
    Incidental findings are common, but rarely clinically significant, in patients with Neuroendocrine Tumours undergoing Gallium68 Dotatate PET CT; results from a one year retrospective review
    Oxford Centre for Diabetes, Endocrinology and Metabolism, Oxford, UK
    OP6.2
    Oral Posters 6 - Endocrine Cancer and Late Effects
    The evaluation of a musculoskeletal health package intervention to prevent bone toxicity in women with gynaecological malignancies undergoing pelvic radiotherapy. The RadBone randomised controlled feasibility study.
    Christie Hospital NHS Foundation Trust, Manchester, UK
    OP6.3
    Oral Posters 6 - Endocrine Cancer and Late Effects
    An unusual presentation of hypoglycaemia: An investigative challenge
    Imperial College London, London, UK
    OP6.4
    Oral Posters 6 - Endocrine Cancer and Late Effects
    Virtual Blood Pressure Monitoring in the Pre-operative Management of Phaeochromocytoma Patients in a Tertiary Centre during the COVID-19 Pandemic
    The Christie NHS Foundation Trust, Manchester, UK
    14:10 - 14:45 
    Endocrine Network Session 1 - Adrenal and Cardiovascular
    Endocrinology, Diabetes & Metabolism Case Reports
    Carrick 1
    Chairs: Dr Miles Levy (University Hospitals of Leicester, Leicester, UK) & Dr Scott Mackenzie (University of Glasgow, Glasgow, UK)
    Endocrine Network Session 1 - Adrenal and Cardiovascular
    Vaccine-Induced Adrenal Haemorrhage
    University Hospital of Wales, Cardiff, UK
    14:10 - 14:45 
    Endocrine Network Session 2 - Bone and Calcium
    Parathyroid UK
    Carrick 2
    Chairs: Professor Jeremy Turner (Norfolk and Norwich University Hospitals NHS Foundation Trust, Norwich, UK) & Dr Caroline Gorvin (University of Birmingham, Birmingham, UK)
    Endocrine Network Session 2 - Bone and Calcium
    Updates and future plans for the Bone and Calcium network
    Norfolk and Norwich University Hospital, Norfolk, UK
    University of Birmingham, Birmingham, UK
    14:10 - 14:45 
    Endocrine Network Session 3 - Endocrine Consequences of Living with and beyond Cancer
    Endocrine-Related Cancer
    Ochil 1
    Chairs: Dr Helen Simpson (University College London Hospital, London, UK) & Claire Higham (The Christie NHS Foundation Trust, Manchester, UK)
    Endocrine Network Session 3 - Endocrine Consequences of Living with and beyond Cancer
    Updates and future plans for the Endocrine Consequences of Living with and beyond Cancer network
    14:10 - 14:45 
    Endocrine Network Session 4 - Endocrine Cancer
    Endocrine Oncology
    Sidlaw Auditorium
    Chair: Kate Lines (University of Oxford, Oxford, UK)
    Endocrine Network Session 4 - Endocrine Cancer
    Hormones, Cancer and COVID - headlines from 2020-21
    Imperial College London, London, UK
    Endocrine Network Session 4 - Endocrine Cancer
    A survey on the management of metastatic PPGL in UK & Ireland

    Unknown speaker

    Cambridge University Hospital NHS Foundation Trust, Cambridge, United Kingdom
    14:10 - 14:45 
    Endocrine Network Session 5 - Metabolism, Obesity and Diabetes
    Endocrinology, Diabetes & Metabolism Case Reports
    Ochil Suite 2 & 3
    Chair: Dr Gavin Bewick (King’s College London, London, UK)
    Endocrine Network Session 5 - Metabolism, Obesity and Diabetes
    What skills, techniques and experience can you gain from visiting another laboratory
    Coventry University, Coventry, UK
    14:10 - 14:45 
    Endocrine Network Session 6 - Neuroendocrinology
    Journal of Endocrinology
    Carrick 3
    Chair: Dr Niki Karavitaki (University of Birmingham, Birmingham, UK)
    Endocrine Network Session 6 - Neuroendocrinology
    Discussion of audits and research and plans for the Network
    Birmingham, UK
    Endocrine Network Session 6 - Neuroendocrinology
    How to follow-up a patient with with Cushing's and remission after surgery
    University of Sheffield, Sheffield, UK
    14:10 - 14:45 
    Endocrine Network Session 7 - Reproductive Endocrinology and Biology
    Journal of Molecular Endocrinology
    Tinto
    Chairs: Professor Colin Duncan (The University of Edinburgh, Edinburgh, UK) & Dr Kim Jonas (King’s College London, London, UK)
    Endocrine Network Session 7 - Reproductive Endocrinology and Biology
    Fertility and its preservation in the transgender population
    Edinburgh, UK
    14:10 - 14:45 
    Endocrine Network Session 8 - Thyroid
    Clinical Endocrinology
    Kilsyth & Moorfoot
    Chairs: Professor Peter Taylor (Cardiff University, Cardiff, UK) & Fraser Gibb (Edinburgh Centre for Endocrinology and Diabetes, Edinburgh, UK)
    Endocrine Network Session 8 - Thyroid
    An overview of thyroid papers
    University of Edinburgh, Edinburgh, UK

    Unknown speaker

    University of Edinburgh, Edinburgh, UK
    Cardiff University, Cardiff, UK
    Endocrine Network Session 8 - Thyroid
    Summary of the NIHR assessment of RFA in thyroid nodules
    University of Birmingham, Birmingham, UK
    Endocrine Network Session 8 - Thyroid
    Updates and future plans for the Thyroid network
    14:50 - 16:05 
    Clinical Management Workshop 2: Widening perspective on reproductive health
    Turner Syndrome Support Society
    Kilsyth & Moorfoot
    Chairs: Dr Richard Quinton (Newcastle University, Newcastle, UK) & Channa Jayasena (Imperial College London, London, UK)
    CMW2.1
    Clinical Management Workshop 2: Widening perspective on reproductive health
    Endometrial health - the role of the specialist menstrual disorders service
    The University of Edinburgh, Edinburgh, UK
    CMW2.2
    Clinical Management Workshop 2: Widening perspective on reproductive health
    Optimising health outcomes following gender reassignment
    St George's Hospital, London, UK
    CMW2.3
    Clinical Management Workshop 2: Widening perspective on reproductive health
    Healthy heart In Turner syndrome
    Oxford, UK
    14:50 - 16:05 
    Early Careers Session
    Sidlaw Auditorium
    Chairs: Jolyon Dales (University Hospitals Leicester NHS Trust, Leicester, UK) & Mariana Norton (Imperial College London, London, UK)
    Early Careers Session
    An insight into a venture capital career
    The University of Edinburgh, Edinburgh, UK
    ECS1.2
    Early Careers Session
    Post-doc to Research Facilitator; making the transition
    University of Birmingham, Birmingham, UK
    Early Careers Session
    Influencing at scale: NHS leadership and shaping policy
    University Hospitals Birmingham, Birmingham, UK
    Early Careers Session
    Clinical teaching careers
    Imperial College London, London, UK
    Early Careers Session
    University research & teaching careers
    Imperial College, London, UK
    14:50 - 16:05 
    Cutting Edge - Use and Abuse Endocrinology: Enhancing Performance At Any Cost?
    Endocrine Connections
    Pentland Auditorium
    Chairs: Dr Helen Turner (Oxford University Hospitals NHS Foundation Trust, Oxford, UK) & Dr Jonathan Hazlehurst (University of Birmingham, Birmingham, UK)
    Cutting Edge - Use and Abuse Endocrinology: Enhancing Performance At Any Cost?
    Adverse effects of anabolic steroid use
    Harvard Medical School, Boston, USA
    Cutting Edge - Use and Abuse Endocrinology: Enhancing Performance At Any Cost?
    GH as a performance enhancing drug
    University of Southampton, Southampton, UK
    Cutting Edge - Use and Abuse Endocrinology: Enhancing Performance At Any Cost?
    Blood doping: climbing to the peak of athletic performance
    Oslo University Hospital, Oslo, Norway
    16:10 - 16:40 
    Plenary 9: Society for Endocrinology Medal Lecture
    Society for Endocrinology
    Pentland Auditorium
    Chair: Professor Ruth Andrew (The University of Edinburgh, Edinburgh, UK)
    PL9
    PL9
    Plenary 9: Society for Endocrinology Medal Lecture
    Revisiting Cushing’s: The power of pre-receptor metabolism
    University of Oxford, Oxford, UK
    16:40 - 17:10 
    Plenary 10: Society for Endocrinology Jubilee Medal Lecture
    Society for Endocrinology
    Pentland Auditorium
    Chair: Professor Mark Gurnell (University of Cambridge, Cambridge, UK)
    PL10
    PL10
    Plenary 10: Society for Endocrinology Jubilee Medal Lecture
    Cancer Treatment Endocrinopathies and growth hormone status throughout life
    The Christie NHS Foundation Trust, Manchester, UK
    17:10 - 17:20 
    Prizes and Awards
    Pentland Auditorium
    17:20 - 17:25 
    Close of Conference
    Pentland Auditorium
Kate	Davies
UK
Tue 09 15:10
NS2.1
Nurses' Session 2: Career Pathways in Endocrine Nursing: Entry points and Academic progression
Advanced Practice and Prescribing
UK
Richard Anderson
Edinburgh, UK
Wed 10 14:10
Endocrine Network Session 7 - Reproductive Endocrinology and Biology
Fertility and its preservation in the transgender population
Edinburgh, UK
Giulia Argentesi
Queen Mary University London, London, UK
Tue 09 15:25
OC4.2
Oral Communications 4 - Adrenal and Cardiovascular
Somatic mutations of GNA11 and GNAQ in CTNNB1-mutant aldosterone-producing adenomas presenting in puberty, pregnancy or menopause.
Queen Mary University London, London, UK
Professor Wiebke Arlt
MRC Laboratory of Medical Sciences, London, UK
Tue 09 12:00
S3.2
Symposium 3: Novel Approaches to the Diagnosis and Treatment of Endocrine Neoplasia
Advances in diagnostics for ACC-a multiomics approach
MRC Laboratory of Medical Sciences, London, UK
Tue 09 12:30
S3.3
Symposium 3: Novel Approaches to the Diagnosis and Treatment of Endocrine Neoplasia
Discussion
University of Oxford, Oxford, UK
Imperial College London, London, UK
University of Oxford, Oxford, UK

Unknown speaker

University of Oxford, Oxford, UK
Imperial College London, London, UK
University of Oxford, Oxford, UK
MRC Laboratory of Medical Sciences, London, UK
Professor  Irina Bancos
Mayo Clinic, Minnesota, USA
Wed 10 11:35
S6.3
Symposium 6: Characterizing the Cortex to Improve Clinical Care
CT characteristics of adrenal nodules to guide management
Mayo Clinic, Minnesota, USA
Professor Rachel Batterham
University College London, London, UK
Tue 09 12:30
S1.3
Symposium 1: Lifestyle Hacks for Metabolic Disease
A new era in gut-hormone based pharmacotherapy for people with obesity?
University College London, London, UK
Professor  Charlotte Bevan
Imperial College London, London, UK
Tue 09 11:30
S2.1
Symposium 2: Nuclear Receptors in Male Reproduction
LXR and testicular function
Imperial College London, London, UK
Wed 10 14:10
Endocrine Network Session 4 - Endocrine Cancer
Hormones, Cancer and COVID - headlines from 2020-21
Imperial College London, London, UK
Dr  Gavin Bewick
King's College London, London, UK
Tue 09 17:40
BPW2.2
Basic Physiology Workshop 2: Model Systems
Ready Player One? 3D Gut endocrinology in a dish
King's College London, London, UK
Kristien Boelaert
University of Birmingham, Birmingham, UK
Tue 09 11:00
OCP1.1
Outstanding Clinical Practitioners Award
Improving the care of patients with thyroid diseases
University of Birmingham, Birmingham, UK
Tue 09 13:05
MTE3
Meet the Expert 3 (Thyroid)
Thyroid disease assessment and management; controversies in the NICE guidelines
University of Birmingham, Birmingham, UK
Wed 10 09:35
FOE1.1
Defining the Future of Endocrinology: SfE Recommendations for Endocrine Services and Training in the Post-COVID NHS
Introduction
University of Sheffield, Sheffield, UK
University of Birmingham, Birmingham, UK
Wed 10 10:10
FOE1.5
Defining the Future of Endocrinology: SfE Recommendations for Endocrine Services and Training in the Post-COVID NHS
Q&A
Leighton Hospital, Cheshire, UK
Homerton University Hospital, London, UK
Homerton University Hospital, London, UK
University of Sheffield, Sheffield, UK

Unknown speaker

Leighton Hospital, Cheshire, UK
Homerton University Hospital, London, UK
Homerton University Hospital, London, UK
University of Sheffield, Sheffield, UK
University of Birmingham, Birmingham, UK
Mid Cheshire Hospitals NHS Foundation Trust
Homerton University Hospital, London, UK
Homerton University Hospital, London, UK
University of Sheffield, Sheffield, UK
Wed 10 14:20
Endocrine Network Session 8 - Thyroid
Summary of the NIHR assessment of RFA in thyroid nodules
University of Birmingham, Birmingham, UK
Dr Laura  Boucai
Memorial Sloane Kettering Cancer center, New York, USA
Wed 10 12:10
MTE4
Meet the Expert 4 (Endocrine Cancer and Late Effects)
Thyroid surveillance after radiotherapy
Memorial Sloane Kettering Cancer center, New York, USA
Abigail Byford
University of Leeds, Leeds, UK
Tue 09 14:03
OP3.2
Oral Posters 3 - Reproductive and Neuroendocrinology
An ex-vivo human placental model demonstrates that temporal fluctuations in maternal glucose in gestational diabetes alter placental transcriptome networks associated vascular development and angiogenesis
University of Leeds, Leeds, UK
Paul Carroll
Guy's and St Thomas' Hospital, London, UK
Mon 08 11:35
CMW1.2
Clinical Management Workshop 1: Pituitary Challenges: Prompt, Practical and Post-op
Acute Cushing's
Guy's and St Thomas' Hospital, London, UK
Ruth Casey
Cambridge University Hospital NHS Foundation Trust, Cambridge, United Kingdom
Mon 08 11:50
HDI1.4
How Do I...?
How do I screen an SDH gene carrier?

Unknown speaker

Cambridge University Hospital NHS Foundation Trust, Cambridge, United Kingdom
Wed 10 14:10
Endocrine Network Session 4 - Endocrine Cancer
A survey on the management of metastatic PPGL in UK & Ireland

Unknown speaker

Cambridge University Hospital NHS Foundation Trust, Cambridge, United Kingdom
Inês  Cebola
Imperial College London, London, United Kingdom
Mon 08 09:45
WIN1
What is New?
What is New in Basic Endocrinology Research?
Imperial College London, London, United Kingdom
Professor Amandine Chaix
University of Utah, Utah, USA
Tue 09 11:30
S1.1
Symposium 1: Lifestyle Hacks for Metabolic Disease
When not to eat; from mice to men
University of Utah, Utah, USA
Paul Chapple
Queen Mary University of London, London, UK
Mon 08 16:20
OC2.6
Oral Communications 2 - Endocrine Cancer and Late Effects
Transcriptomic analysis of succinate dehydrogenase subunit deleted cells to identify molecular mechanisms underlying the increased metastatic potential of SDHB-deficient tumours
Queen Mary University of London, London, UK
Victoria Chatzimavridou Grigoriadou
Christie Hospital NHS Foundation Trust, Manchester, UK
Wed 10 13:38
OP6.2
Oral Posters 6 - Endocrine Cancer and Late Effects
The evaluation of a musculoskeletal health package intervention to prevent bone toxicity in women with gynaecological malignancies undergoing pelvic radiotherapy. The RadBone randomised controlled feasibility study.
Christie Hospital NHS Foundation Trust, Manchester, UK
Professor Triantafyllos  Chavakis
Dresden University of Technology, Dresden, Germany
Mon 08 12:05
BPW1.3
Basic Physiology Workshop 1: New Techniques and Approaches
What you need to know about immunometabolism
Dresden University of Technology, Dresden, Germany
Tim Cheetham
Newcastle, UK
Tue 09 15:10
OC6.1
Oral Communications 6 - Thyroid
Adjuvant Rituximab – exploratory trial in young people with Graves’ disease
Newcastle, UK
Pei Chia Eng
Imperial College London, London, UK
Wed 10 13:46
OP6.3
Oral Posters 6 - Endocrine Cancer and Late Effects
An unusual presentation of hypoglycaemia: An investigative challenge
Imperial College London, London, UK
Dri Choa
Imperial College Healthcare NHS Trust, London, UK
Mon 08 13:01
OP1.3
Oral Posters 1 - Thyroid
Thyroid Endocrine Nurse Service: Improving patient experience
Imperial College Healthcare NHS Trust, London, UK
T’ng Choong Kwok
University of Edinburgh, Edinburgh, UK
Mon 08 15:05
OC3.1
Oral Communications 3 - Metabolism, Obesity and Diabetes
The serotonin transporter SLC6A4 protects human brown adipose tissue from serotonin-mediated suppression of thermogenesis
University of Edinburgh, Edinburgh, UK
Professor Michael Collins
National Institute of Dental and Craniofacial Research, Bethesda MD, USA
Wed 10 11:35
S5.3
Symposium 5: What is New in Calcium and Bone
Targeting the Calcium-Sensing Receptor
National Institute of Dental and Craniofacial Research, Bethesda MD, USA
Professor Sabine Costagliola
Université de Genève, Brussels, Belgium
Tue 09 18:10
BPW2.3
Basic Physiology Workshop 2: Model Systems
Organ on a Chip
Université de Genève, Brussels, Belgium
Mr Sherwin Criseno
University Hospitals Birmingham, Birmingham, UK
Tue 09 11:00
ENA1
Endocrine Nurse Award & Nikki Kieffer Medal
Endocrine Nurse Award 2020
University Hospitals Birmingham, Birmingham, UK
Tue 09 17:10
NS3.2
Nurses' Session 3: Management of Endocrine Conditions in the time of COVID
Management of adrenal insufficiency
University Hospitals Birmingham, Birmingham, UK
Tue 09 17:10
NS3.4
Nurses' Session 3: Management of Endocrine Conditions in the time of COVID
Management of pituitary tumours
University Hospitals Birmingham, Birmingham, UK
Tue 09 17:10
NS3.5
Nurses' Session 3: Management of Endocrine Conditions in the time of COVID
Management of calcium disorders and osteoporosis
University Hospitals Birmingham, Birmingham, UK
Dr Rachel Crowley
St Vincent's University Hospital, Dublin, Ireland
Tue 09 17:10
HDI2.1
How Do I...? 2
How do I investigate abnormal alkaline phosphatase and bone context?
St Vincent's University Hospital, Dublin, Ireland
Mr Simon  Cudlip
John Radcliffe Hospital, Oxford, UK
Mon 08 12:05
CMW1.3
Clinical Management Workshop 1: Pituitary Challenges: Prompt, Practical and Post-op
Post op management
John Radcliffe Hospital, Oxford, UK
Milad Darrat
Royal Victoria Hospital, Belfast, UK
Tue 09 16:25
OC6.6
Oral Communications 6 - Thyroid
Forty years' experience of national screening programme for congenital hypothyroidism in Northern Ireland.
Queen's University Belfast, Belfast, UK
Royal Victoria Hospital, Belfast, UK
Kate Davies
London South Bank University, London, UK
Tue 09 16:15
NS2.4
Nurses' Session 2: Career Pathways in Endocrine Nursing: Entry points and Academic progression
Discussion
Oxford Centre for Diabetes, Endocrinology and Metabolism, Oxford, UK
Salford Royal NHS Foundation Trust, Salford, UK
London South Bank University, London, UK
University of Oxford Hospitals, Oxford, UK
University of Birmingham, Birmingham, UK
Dr Elisa De Franco
University of Exeter, Exeter, UK
Tue 09 09:35
EC1.1
Early Careers and Plenary Orals
Early Career Prize Lecture Basic Science: Using gene discovery to identify new key regulators of beta cell development
University of Exeter, Exeter, UK
Dr Yvette Dehnes
Oslo University Hospital, Oslo, Norway
Wed 10 15:40
Cutting Edge - Use and Abuse Endocrinology: Enhancing Performance At Any Cost?
Blood doping: climbing to the peak of athletic performance
Oslo University Hospital, Oslo, Norway
Waljit Dhillo
London, UK
Wed 10 12:10
MTE5
Meet the Expert 5 (Reproductive and Neuroendocrinology)
I want KNDy: What's New in Flushing and Fertility?
London, UK
MDSA Dilrukshi
Oxford Centre for Diabetes, Endocrinology and Metabolism, Oxford, UK
Mon 08 13:28
OP2.2
Oral Posters 2 - Adrenal and Cardiovascular
Single-centre analysis of 900 short synacthen tests: do pre-test clinical or biochemical variables predict failure?
Oxford Centre for Diabetes, Endocrinology and Metabolism, Oxford, UK
Professor William Drake
St Bartholomew’s Hospital, London, UK
Mon 08 18:15
D1.1
Debate: TO BLOCK, OR NOT TO BLOCK, THAT IS THE QUESTION: Controversies in peri-operative management of catecholamine producing tumours
For the motion
St Bartholomew’s Hospital, London, UK
Maralyn Druce
Barts Health NHS Trust, London, UK
Mon 08 10:00
WIN2
What is New?
What is New in Clinical Endocrinology Research?
Barts Health NHS Trust, London, UK
Rebecca Dumbell
Nottingham Trent University, Nottingham, UK
Tue 09 14:46
OP4.3
Oral Posters 4 - Metabolism, Obesity and Diabetes
The Chemerin-CMKLR1 Axis is Functionally Important for Central Regulation of Energy Homeostasis
Nottingham Trent University, Nottingham, UK
Muhammad  Fahad Arshad
University of Sheffield, Sheffield, UK
Wed 10 12:55
OP5.1
Oral Posters 5 - Bone and Calcium
Parathyroid hormone (PTH) of 1.6 pmol/L or more at 6 months is associated with delayed recovery of parathyroid function in post-surgical hypoparathyroidism (PoSH)
University of Sheffield, Sheffield, UK
Professor Sadaf Farooqi
MRC Institute of Metabolic Science, Cambridge, UK
Mon 08 17:45
PL3
Plenary 3: Society for Endocrinology Dale Medal Lecture
The biology of weight regulation
MRC Institute of Metabolic Science, Cambridge, UK
Professor Mark Febbraio
Monash University, Melbourne, Australia
Tue 09 09:00
PL5
Plenary 5: Society for Endocrinology International Medal Lecture
Activation of the gp130 receptor: a panacea for the treatment of metabolic diseases?
Monash University, Melbourne, Australia
Jonathan Fenn
The Royal Wolverhampton NHS Trust, Wolverhampton, UK
Wed 10 13:19
OP5.4
Oral Posters 5 - Bone and Calcium
Normocalcaemic hyperparathyroidism: Impact of assay and reference range differences on the diagnosis
The Royal Wolverhampton NHS Trust, Wolverhampton, UK
Claire Fletcher
Imperial College London, London, UK
Mon 08 16:05
OC2.5
Oral Communications 2 - Endocrine Cancer and Late Effects
A novel MiR-346-directed DNA damage mechanism is regulated by its interaction with long non-coding RNA, NORAD, in prostate cancer
Imperial College London, London, UK
Tue 09 12:30
S3.3
Symposium 3: Novel Approaches to the Diagnosis and Treatment of Endocrine Neoplasia
Discussion
University of Oxford, Oxford, UK
Imperial College London, London, UK
University of Oxford, Oxford, UK

Unknown speaker

University of Oxford, Oxford, UK
Imperial College London, London, UK
University of Oxford, Oxford, UK
MRC Laboratory of Medical Sciences, London, UK
Dr Katharine  Fox
The University of Edinburgh, Edinburgh, UK
Wed 10 14:50
Early Careers Session
An insight into a venture capital career
The University of Edinburgh, Edinburgh, UK
Marie Freel
Queen Elizabeth University Hospital, Glasgow, UK
Tue 09 18:10
HDI2.5
How Do I...? 2
How do I confirm biochemical diagnosis of primary aldosteronism?
Queen Elizabeth University Hospital, Glasgow, UK
Professor Jeffrey  Friedman
Rockefeller University, New York, USA
Mon 08 10:15
AN1
SfE BES 75th Anniversary Lecture
Discovery of a new hormone, leptin, and its roles in health and disease
Rockefeller University, New York, USA
Aoife Garrahy
Oxford Centre for Diabetes, Endocrinology and Metabolism, Oxford, UK
Wed 10 13:30
OP6.1
Oral Posters 6 - Endocrine Cancer and Late Effects
Incidental findings are common, but rarely clinically significant, in patients with Neuroendocrine Tumours undergoing Gallium68 Dotatate PET CT; results from a one year retrospective review
Oxford Centre for Diabetes, Endocrinology and Metabolism, Oxford, UK
Dr Arjun  Ghosh
University College London Hospital, London, UK
Tue 09 17:55
HDI2.4
How Do I...? 2
How do I screen for cardiovascular effects of cancer treatments?
University College London Hospital, London, UK
Dr Fraser Gibb
University of Edinburgh, Edinburgh, UK
Wed 10 14:10
Endocrine Network Session 8 - Thyroid
An overview of thyroid papers
University of Edinburgh, Edinburgh, UK

Unknown speaker

University of Edinburgh, Edinburgh, UK
Cardiff University, Cardiff, UK
Dr Tim Giles
University of Birmingham, Birmingham, UK
Wed 10 15:05
ECS1.2
Early Careers Session
Post-doc to Research Facilitator; making the transition
University of Birmingham, Birmingham, UK
Professor Neil Gittoes
University Hospitals Birmingham, Birmingham, UK
Wed 10 15:20
Early Careers Session
Influencing at scale: NHS leadership and shaping policy
University Hospitals Birmingham, Birmingham, UK
Michelle Goldsworthy
University of Oxford, Oxford, UK
Tue 09 16:10
OC5.5
Oral Communications 5 - Bone and Calcium
Diacylglycerol kinase delta haploinsufficiency in mice causes hypocalcaemia: relevance to human Autosomal Dominant Hypoclacemia (ADH)
University of Oxford, Oxford, UK
Caroline Gorvin
University of Birmingham, Birmingham, UK
Wed 10 14:10
Endocrine Network Session 2 - Bone and Calcium
Updates and future plans for the Bone and Calcium network
Norfolk and Norwich University Hospital, Norfolk, UK
University of Birmingham, Birmingham, UK
Ross Hamblin
University of Birmingham, Birmingham, UK
Mon 08 16:05
OC1.5
Oral Communications 1 - Reproductive and Neuroendocrinology
Is radiotherapy for pituitary adenoma or craniopharyngioma associated with increased risk of second brain tumour? A long-term multi-centre study of 3,679 patients
University of Birmingham, Birmingham, UK
Professor  Gary Hammer
University of Michigan, Michigan, USA
Wed 10 09:00
PL8
Plenary 8: CET Visiting Professor Lecture
Enigma of the Adrenal SHH Progenitor
University of Michigan, Michigan, USA
Morten S Hansen
Odense University Hospital, Odense, Denmark
Tue 09 15:25
OC5.2
Oral Communications 5 - Bone and Calcium
Gastric inhibitory polypeptide (GIP) reduces human osteoclast activity by suppressing multiple signalling pathways
Odense University Hospital, Odense, Denmark
Ian Hay
Mayo Clinic, Rochester, MN, USA
Tue 09 15:40
OC6.3
Oral Communications 6 - Thyroid
Failure of Radioiodine Remnant Ablation to Improve Postoperative Outcome in 2668 Adult Patients with AJCC/pTNM stage I Papillary Thyroid Carcinoma
Mayo Clinic, Rochester, MN, USA
Professor  Lora Heisler
University of Aberdeen, Aberdeen, UK
Wed 10 09:35
SK2.1
Basic Skills: Grants and Teaching
Grants
University of Aberdeen, Aberdeen, UK
Dr Heike Heuer
Essen, Germany
Mon 08 14:00
PL1
Plenary 1: British Thyroid Association Pitt-Rivers Lecture
Role of thyroid hormone transporters in brain development and function
Essen, Germany
Claire Higham
The Christie NHS Foundation Trust, Manchester, UK
Mon 08 11:05
HDI1.1
How Do I...?
How should I investigate for effect of radiotherapy on the hypothalamus and pituitary?

Unknown speaker

The Christie NHS Foundation Trust, Manchester, UK
Professor Richard Holt
University of Southampton, Southampton, UK
Wed 10 15:15
Cutting Edge - Use and Abuse Endocrinology: Enhancing Performance At Any Cost?
GH as a performance enhancing drug
University of Southampton, Southampton, UK
Samuel Hoskyns
Newcastle University, Newcastle, UK
Tue 09 16:25
OC5.6
Oral Communications 5 - Bone and Calcium
The role of vitamin D supplementation in critically ill patients with COVID-19
Newcastle University, Newcastle, UK
Professor Ilpo Huhtaniemi
Imperial College London, London, UK
Tue 09 17:10
SE1.1
Senior Endocrinologists' Session
Are gonadotrophins more than gonadotrophins?
Imperial College London, London, UK
Shazia  Hussain
Homerton University Hospital, London, UK
Wed 10 09:50
FOE1.3
Defining the Future of Endocrinology: SfE Recommendations for Endocrine Services and Training in the Post-COVID NHS
Enhancing and Protecting Training
Homerton University Hospital, London, UK
Wed 10 10:10
FOE1.5
Defining the Future of Endocrinology: SfE Recommendations for Endocrine Services and Training in the Post-COVID NHS
Q&A
Leighton Hospital, Cheshire, UK
Homerton University Hospital, London, UK
Homerton University Hospital, London, UK
University of Sheffield, Sheffield, UK

Unknown speaker

Leighton Hospital, Cheshire, UK
Homerton University Hospital, London, UK
Homerton University Hospital, London, UK
University of Sheffield, Sheffield, UK
University of Birmingham, Birmingham, UK
Mid Cheshire Hospitals NHS Foundation Trust
Homerton University Hospital, London, UK
Homerton University Hospital, London, UK
University of Sheffield, Sheffield, UK
Dr  Fizzah Iqbal
University Hospital of Wales, Cardiff, UK
Wed 10 14:10
Endocrine Network Session 1 - Adrenal and Cardiovascular
Vaccine-Induced Adrenal Haemorrhage
University Hospital of Wales, Cardiff, UK
Professor  Richard Ivell
University of Nottingham, Nottingham , UK
Tue 09 18:10
SE1.3
Senior Endocrinologists' Session
INSL3: a new index of testis function in puberty and aging
University of Nottingham, Nottingham , UK
Dr Louise Izatt
Department of Clinical Genetics, Guy's and St Thomas' NHS Foundation Trust, London , UK
Wed 10 09:35
SK1.1
Clinical Skills: Genetics for the Endocrinologist
The Geneticist's Perspective
Department of Clinical Genetics, Guy's and St Thomas' NHS Foundation Trust, London , UK
Dr Sue Jackson
The Pituitary Foundation, Bristol, UK
Tue 09 12:30
NS1.3
Nurses' Session 1: Acromegaly
Addressing the unmet psychosocial needs of patients with treated Acromegaly
The Pituitary Foundation, Bristol, UK
Margot Jacobs
King's College London, London, UK
Mon 08 15:20
OC3.2
Oral Communications 3 - Metabolism, Obesity and Diabetes
Comparing the transcriptional landscape between lean and obese mice within the small intestinal segments
King's College London, London, UK
Dr Sheba Jarvis
Imperial College London, London, UK
Tue 09 11:00
TAA1
Teaching Achievement Award
Teaching fertile minds- seeking out teaching opportunities during clinical training
Imperial College London, London, UK
Channa Jayasena
Imperial College London, London, UK
Tue 09 08:00
ARG1.2
The New SfE Androgen Replacement Guidelines
Changes to safety monitoring for androgen replacement in men
Imperial College London, London, UK
Kishan Jethwa
Norfolk and Norwich University Hospitals NHS Foundation Trust, Norwich, UK
Tue 09 15:40
OC5.3
Oral Communications 5 - Bone and Calcium
Role of Intact and C-Terminal FGF-23 Assays in the Investigation of Metabolic Bone Disease.
Norfolk and Norwich University Hospitals NHS Foundation Trust, Norwich, UK
Dr Gillian Johnson
King's College London, London, UK
Mon 08 16:20
OC1.6
Oral Communications 1 - Reproductive and Neuroendocrinology
Differential follicle stimulating hormone glycosylation modulates pre-antral follicle growth and survival rates

Unknown speaker

King's College London, London, UK
Professor George Kahaly
Johannes Gutenberg University Medical Center, Mianz, Germany
Wed 10 11:05
S4.2
Symposium 4: Understanding Pathogenesis: Development of Novel Treatments
Thyroid Eye Disease
Johannes Gutenberg University Medical Center, Mianz, Germany
Sonia Kaniuka-Jakubowska
Medical University of Gdansk, Gdansk, Poland
Tue 09 13:55
OP3.1
Oral Posters 3 - Reproductive and Neuroendocrinology
Discordant growth hormone and insulin like growth factor-1 values are associated with an increased mortality over concordant normal values in patients treated for acromegaly
Medical University of Gdansk, Gdansk, Poland
Niki Karavitaki
Birmingham, UK
Mon 08 11:05
CMW1.1
Clinical Management Workshop 1: Pituitary Challenges: Prompt, Practical and Post-op
Apoplexy
Birmingham, UK
Tue 09 12:00
NS1.2
Nurses' Session 1: Acromegaly
Biochemical cure – is this enough?
Birmingham, UK
Wed 10 14:10
Endocrine Network Session 6 - Neuroendocrinology
Discussion of audits and research and plans for the Network
Birmingham, UK
Lucy Kayes
Queen's University Belfast, Belfast, UK
Tue 09 16:25
OC6.6
Oral Communications 6 - Thyroid
Forty years' experience of national screening programme for congenital hypothyroidism in Northern Ireland.
Queen's University Belfast, Belfast, UK
Royal Victoria Hospital, Belfast, UK
Kathryn Kinsella
Salford Royal NHS Foundation Trust, Salford, UK
Tue 09 16:15
NS2.4
Nurses' Session 2: Career Pathways in Endocrine Nursing: Entry points and Academic progression
Discussion
Oxford Centre for Diabetes, Endocrinology and Metabolism, Oxford, UK
Salford Royal NHS Foundation Trust, Salford, UK
London South Bank University, London, UK
University of Oxford Hospitals, Oxford, UK
University of Birmingham, Birmingham, UK
Merve Kocbiyik
University of Birmingham Institute of Metabolism and System Research, Birmingham, UK
Mon 08 15:50
OC2.4
Oral Communications 2 - Endocrine Cancer and Late Effects
PBF phosphorylation regulates cell motility of thyroid and breast cancer cells
University of Birmingham Institute of Metabolism and System Research, Birmingham, UK
Kreepa Kooblall
University of Oxford, Oxford, UK
Tue 09 15:55
OC5.4
Oral Communications 5 - Bone and Calcium
Nuclear factor I/X (NFIX) regulates the transcriptional activity of the cellular retinoic acid binding protein 2 (CRABP2) promoter and altersCRABP2 expression in Marshall-Smith Syndrome (MSS) patients.
University of Oxford, Oxford, UK
Dr Kenneth  Korach
National Institute of Environmental Health Sciences, Durham, USA
Tue 09 17:40
SE1.2
Senior Endocrinologists' Session
What in the World is EIS?
National Institute of Environmental Health Sciences, Durham, USA
Professor Márta Korbonits
London, London, UK
Wed 10 08:30
PL7
Plenary 7: Clinical Endocrinology Trust Lecture
The yin and yang of hormones and glucose

Unknown speaker

London, London, UK
Georgios Krilis
Centre for Cardiovascular Science, Edinburgh, United Kingdom
Tue 09 16:25
OC4.6
Oral Communications 4 - Adrenal and Cardiovascular
Glucocorticoids and the Vascular Molecular Clock : Implications in Vascular Function Control
Centre for Cardiovascular Science, Edinburgh, United Kingdom
Tom Kurzawinski
University College London Hospitals NHS Foundation Trust, London, UK
Mon 08 15:05
OC2.1
Oral Communications 2 - Endocrine Cancer and Late Effects
Outcomes of surgery and treatment with selective RET TK inhibitor Selpercatinib in children with MEN2 and advanced MTC.

Unknown speaker

University College London Hospitals NHS Foundation Trust, London, UK
Dr Kate Laycock
Homerton University Hospital, London, UK
Wed 10 10:00
FOE1.4
Defining the Future of Endocrinology: SfE Recommendations for Endocrine Services and Training in the Post-COVID NHS
The Society for Endocrinology Resource Hub
Homerton University Hospital, London, UK
Dr Kate  Laycock
Homerton University Hospital, London, UK
Wed 10 10:10
FOE1.5
Defining the Future of Endocrinology: SfE Recommendations for Endocrine Services and Training in the Post-COVID NHS
Q&A
Leighton Hospital, Cheshire, UK
Homerton University Hospital, London, UK
Homerton University Hospital, London, UK
University of Sheffield, Sheffield, UK

Unknown speaker

Leighton Hospital, Cheshire, UK
Homerton University Hospital, London, UK
Homerton University Hospital, London, UK
University of Sheffield, Sheffield, UK
University of Birmingham, Birmingham, UK
Mid Cheshire Hospitals NHS Foundation Trust
Homerton University Hospital, London, UK
Homerton University Hospital, London, UK
University of Sheffield, Sheffield, UK
Alexander Lewis
Diurnal Ltd, Cardiff, United Kingdom
Tue 09 10:15
EC1.3
Early Careers and Plenary Orals
CET Best Clinical Abstract: Phase 3 and extension study of modified-release hydrocortisone in the treatment of congenital adrenal hyperplasia
Diurnal Ltd, Cardiff, United Kingdom
Diurnal Ltd, Sheffield, UK
Dr Kate Lines
University of Oxford, Oxford, UK
Tue 09 12:30
S3.3
Symposium 3: Novel Approaches to the Diagnosis and Treatment of Endocrine Neoplasia
Discussion
University of Oxford, Oxford, UK
Imperial College London, London, UK
University of Oxford, Oxford, UK

Unknown speaker

University of Oxford, Oxford, UK
Imperial College London, London, UK
University of Oxford, Oxford, UK
MRC Laboratory of Medical Sciences, London, UK
Mrs  Helen  Loo
University of Oxford Hospitals, Oxford, UK
Tue 09 15:30
NS2.2
Nurses' Session 2: Career Pathways in Endocrine Nursing: Entry points and Academic progression
Graduate Experience – Masters Module in Endocrine Nursing
University of Oxford Hospitals, Oxford, UK
Tue 09 16:15
NS2.4
Nurses' Session 2: Career Pathways in Endocrine Nursing: Entry points and Academic progression
Discussion
Oxford Centre for Diabetes, Endocrinology and Metabolism, Oxford, UK
Salford Royal NHS Foundation Trust, Salford, UK
London South Bank University, London, UK
University of Oxford Hospitals, Oxford, UK
University of Birmingham, Birmingham, UK
Tatiana Lopes
Imperial College London, London, UK
Mon 08 15:35
OC2.3
Oral Communications 2 - Endocrine Cancer and Late Effects
A novel in vivo platform for studying tumour vascularization and endocrine responses
Imperial College London, London, UK
Ms Julie  Lynch
St James’s Hospital, Leeds, UK
Tue 09 11:30
NS1.1
Nurses' Session 1: Acromegaly
Advances in the management of Acromegaly 2021
St James’s Hospital, Leeds, UK
James MacFarlane
University of Cambridge and Cambridge University Hospitals, Cambridge, UK
Tue 09 14:11
OP3.3
Oral Posters 3 - Reproductive and Neuroendocrinology
‘Suppression imaging’ – a novel PET technique for increasing confidence in the localisation of secretory pituitary microadenomas
University of Cambridge and Cambridge University Hospitals, Cambridge, UK
Ms. Anne Marland
Oxford Centre for Diabetes, Endocrinology and Metabolism, Oxford, UK
Tue 09 11:15
NKM1
Endocrine Nurse Award & Nikki Kieffer Medal
Nikki Kieffer Medal
Oxford Centre for Diabetes, Endocrinology and Metabolism, Oxford, UK
Tue 09 16:15
NS2.4
Nurses' Session 2: Career Pathways in Endocrine Nursing: Entry points and Academic progression
Discussion
Oxford Centre for Diabetes, Endocrinology and Metabolism, Oxford, UK
Salford Royal NHS Foundation Trust, Salford, UK
London South Bank University, London, UK
University of Oxford Hospitals, Oxford, UK
University of Birmingham, Birmingham, UK
Professor  Niamh Martin
Imperial College London, London, UK
Tue 09 11:15
TAA2
Teaching Achievement Award
Developing a Career in Education
Imperial College London, London, UK
Wed 10 15:35
Early Careers Session
Clinical teaching careers
Imperial College London, London, UK
Tae Matsumoto
Nippon Medical School, Tokyo, Japan
Tue 09 15:10
OC5.1
Oral Communications 5 - Bone and Calcium
Successful adeno-associated virus mediated neonatal gene therapy treatment of hypophosphatasia murine model resulted in bone maturation and increased survival to at least 18 months
Nippon Medical School, Tokyo, Japan
Dr Jackie  Maybin
The University of Edinburgh, Edinburgh, UK
Wed 10 14:50
CMW2.1
Clinical Management Workshop 2: Widening perspective on reproductive health
Endometrial health - the role of the specialist menstrual disorders service
The University of Edinburgh, Edinburgh, UK
Steffen Mayerl
University of Duisburg-Essen, Essen, Germany
Tue 09 15:25
OC6.2
Oral Communications 6 - Thyroid
Concerted action of TH transporters MCT8 and OATP1C1 regulates adult hippocampal neurogenesis and hippocampal function in mice
University of Duisburg-Essen, Essen, Germany
Dr Michelle McDonald
Garvan Institute of Medical Research, Sydney, Australia
Wed 10 10:35
S5.1
Symposium 5: What is New in Calcium and Bone
Osteomorphs: a newcell entity regulating bone resorption
Garvan Institute of Medical Research, Sydney, Australia
Eka Melson
MRC Laboratory of Medical Sciences and Imperial College London, Birmingham, UK
Mon 08 15:35
OC3.3
Oral Communications 3 - Metabolism, Obesity and Diabetes
Sex-specific risk of obesity and cardiometabolic disease in low- and middle-income countries (LMICs): a meta-analysis in 681929 individuals
MRC Laboratory of Medical Sciences and Imperial College London, Birmingham, UK
Emily L. Miedzybrodzka
Wellcome Trust, Cambridge, UK
Mon 08 16:20
OC3.6
Oral Communications 3 - Metabolism, Obesity and Diabetes
Stimulation of motilin secretion by bile, free fatty acids and acidification in human duodenal organoids
Wellcome Trust, Cambridge, UK
Rebecca Mile
The Christie NHS Foundation Trust, Manchester, UK
Wed 10 13:54
OP6.4
Oral Posters 6 - Endocrine Cancer and Late Effects
Virtual Blood Pressure Monitoring in the Pre-operative Management of Phaeochromocytoma Patients in a Tertiary Centre during the COVID-19 Pandemic
The Christie NHS Foundation Trust, Manchester, UK
Edouard G Mills
Imperial College London, London, UK
Mon 08 15:50
OC1.4
Oral Communications 1 - Reproductive and Neuroendocrinology
Intranasal kisspeptin administration stimulates reproductive hormone secretion in healthy men
Imperial College London, London, UK
Anisha Mistry
Queen Mary University of London, London, UK
Mon 08 15:35
OC1.3
Oral Communications 1 - Reproductive and Neuroendocrinology
Acromegalic cardiomyopathy in pituitary-specific aryl hydrocarbon receptor interacting protein (Aip) gene knockout animals

Unknown speaker

Queen Mary University of London, London, UK
Dr  David D Moore
University of California, California, USA
Tue 09 08:30
PL4
Plenary 4: Society for Endocrinology Transatlantic Medal Lecture
Feast and famine: nuclear receptor control of liver energy balance
University of California, California, USA
Carla Moran
Beacon Hospital and University College Dublin, Dublin, Ireland
Tue 09 18:25
HDI2.6
How Do I...? 2
How do I approach isolated hypothyroxinaemia?
Beacon Hospital and University College Dublin, Dublin, Ireland
Dr James Moss
Imperial College London, London, UK
Wed 10 09:55
SK2.2
Basic Skills: Grants and Teaching
Teaching
Imperial College London, London, UK
Kenzo Motohashi
University of Newcastle, Newcastle, UK
Wed 10 13:11
OP5.3
Oral Posters 5 - Bone and Calcium
Vitamin D deficiency is highly prevalent among patients who died from COVID-19 in the North-East of England.
University of Newcastle, Newcastle, UK
John Newell-Price
University of Sheffield, Sheffield, UK
Wed 10 09:35
FOE1.1
Defining the Future of Endocrinology: SfE Recommendations for Endocrine Services and Training in the Post-COVID NHS
Introduction
University of Sheffield, Sheffield, UK
University of Birmingham, Birmingham, UK
Wed 10 10:10
FOE1.5
Defining the Future of Endocrinology: SfE Recommendations for Endocrine Services and Training in the Post-COVID NHS
Q&A
Leighton Hospital, Cheshire, UK
Homerton University Hospital, London, UK
Homerton University Hospital, London, UK
University of Sheffield, Sheffield, UK

Unknown speaker

Leighton Hospital, Cheshire, UK
Homerton University Hospital, London, UK
Homerton University Hospital, London, UK
University of Sheffield, Sheffield, UK
University of Birmingham, Birmingham, UK
Mid Cheshire Hospitals NHS Foundation Trust
Homerton University Hospital, London, UK
Homerton University Hospital, London, UK
University of Sheffield, Sheffield, UK
Wed 10 14:15
Endocrine Network Session 6 - Neuroendocrinology
How to follow-up a patient with with Cushing's and remission after surgery
University of Sheffield, Sheffield, UK
Dr Paul Newey
University of Dundee, Dundee, United Kingdom
Wed 10 09:55
SK1.2
Clinical Skills: Genetics for the Endocrinologist
The Endocrinologist's Perspective
University of Dundee, Dundee, United Kingdom
Miss Mariana  Norton
Imperial College London, London, UK
Tue 09 10:25
EC1.4
Early Careers and Plenary Orals
CET Best Basic Abstract: The vagal calcium sensing receptor mediates the effect of protein ingestion on insulin release and regulates macronutrient metabolism
Imperial College London, London, UK
Dr  Elizabeth  Orchard
Oxford, UK
Wed 10 15:40
CMW2.3
Clinical Management Workshop 2: Widening perspective on reproductive health
Healthy heart In Turner syndrome
Oxford, UK
Dr Bryn Owen
Imperial College, London, UK
Wed 10 15:50
Early Careers Session
University research & teaching careers
Imperial College, London, UK
Simon Pearce
Newcastle University, Newcastle, UK
Wed 10 10:35
S4.1
Symposium 4: Understanding Pathogenesis: Development of Novel Treatments
Graves' disease
Newcastle University, Newcastle, UK
Dr Nicola Peel
Northern General Hospital, Sheffield, UK
Tue 09 13:05
MTE2
Meet the Expert 2 (Bone and Calcium)
Measuring bone markers
Northern General Hospital, Sheffield, UK
Dr Karina  Pena
University of Pittsburgh, Pittsburgh, USA
Wed 10 11:05
S5.2
Symposium 5: What is New in Calcium and Bone
Location Bias in cAMP and PTHR Biology
University of Pittsburgh, Pittsburgh, USA
Siobhan Pender
Guy's and St. Thomas' NHS Foundation Trust, London, UK
Tue 09 13:05
MTE7.2
Meet the Expert 7 (Nurse)
How adolescent care is different to adults or children
Guy's and St. Thomas' NHS Foundation Trust, London, UK
Phyllis Phuah
Imperial College London, London, UK
Mon 08 16:05
OC3.5
Oral Communications 3 - Metabolism, Obesity and Diabetes
Microbial tryptophan metabolites modulate L-cell-induced GLP-1 secretion to improve glucose homeostasis
Imperial College London, London, UK
George Pooley
United Lincolnshire Hospitals NHS Trust, Lincoln, UK
Mon 08 13:09
OP1.4
Oral Posters 1 - Thyroid
Autoimmune thyrotoxicosis: is first line treatment with anti-thyroid medication good enough?
United Lincolnshire Hospitals NHS Trust, Lincoln, UK
Dr  Harrison  Pope
Harvard Medical School, Boston, USA
Wed 10 14:50
Cutting Edge - Use and Abuse Endocrinology: Enhancing Performance At Any Cost?
Adverse effects of anabolic steroid use
Harvard Medical School, Boston, USA
Alessandro Prete
University of Birmingham, Birmingham, UK
Tue 09 09:55
EC1.2
Early Careers and Plenary Orals
Early Career Prize Lecture Clinical: Cardiometabolic disease burden and urine steroid metabolome in benign adrenocortical tumours: a case-control study
University of Birmingham, Birmingham, UK
Richard Quinton
Imperial College London, London, UK
Tue 09 07:40
ARG1.1
The New SfE Androgen Replacement Guidelines
Androgen replacement in men: Classification, diagnosis and biochemical assessment
Imperial College London, London, UK
Tue 09 17:25
HDI2.2
How Do I...? 2
How do I diagnose and manage a low testosterone in men with obesity?
Imperial College London, London, UK
Ashutosh Rai
Queen Mary University of London, London, UK
Mon 08 15:20
OC1.2
Oral Communications 1 - Reproductive and Neuroendocrinology
Hyper-phosphorylation of β-catenin at Serine552 correlates with invasion and predicts recurrence of non-functioning pituitary tumours (NFPTs)
Queen Mary University of London, London, UK
Professor Sir  Peter  Ratcliffe
Nuffield Department of Medicine, Oxford, UK
Mon 08 17:00
PR1
Presidential Lecture
Elucidation of cellular oxygen sensing mechanisms: implications for medicine
Nuffield Department of Medicine, Oxford, UK
Martin Read
University of Birmingham, Birmingham, UK
Mon 08 15:20
OC2.2
Oral Communications 2 - Endocrine Cancer and Late Effects
An emerging role for proteostasis modulators targeting NIS activity to enhance radioiodide therapy in thyroid cancer
University of Birmingham, Birmingham, UK
Professor Nicole Reisch
Munich, Germany
Tue 09 13:05
MTE1
Meet the Expert 1 (Adrenal and Cardiovascular)
Preconception in pregnancy care in CAH
Munich, Germany
Professor  Rebecca  Reynolds
The University of Edinburgh, Edinburgh, UK
Tue 09 17:40
HDI2.3
How Do I...? 2
How do I manage pituitary macroadenoma in pregnancy?
The University of Edinburgh, Edinburgh, UK
Dr Douglas Robertson
Leighton Hospital, Cheshire, UK
Wed 10 09:40
FOE1.2
Defining the Future of Endocrinology: SfE Recommendations for Endocrine Services and Training in the Post-COVID NHS
The Primary-Secondary Care Interface
Leighton Hospital, Cheshire, UK
Mid Cheshire Hospitals NHS Foundation Trust
Wed 10 10:10
FOE1.5
Defining the Future of Endocrinology: SfE Recommendations for Endocrine Services and Training in the Post-COVID NHS
Q&A
Leighton Hospital, Cheshire, UK
Homerton University Hospital, London, UK
Homerton University Hospital, London, UK
University of Sheffield, Sheffield, UK

Unknown speaker

Leighton Hospital, Cheshire, UK
Homerton University Hospital, London, UK
Homerton University Hospital, London, UK
University of Sheffield, Sheffield, UK
University of Birmingham, Birmingham, UK
Mid Cheshire Hospitals NHS Foundation Trust
Homerton University Hospital, London, UK
Homerton University Hospital, London, UK
University of Sheffield, Sheffield, UK
Douglas  Robertson
Mid Cheshire Hospitals NHS Foundation Trust
Wed 10 09:40
FOE1.2
Defining the Future of Endocrinology: SfE Recommendations for Endocrine Services and Training in the Post-COVID NHS
The Primary-Secondary Care Interface
Leighton Hospital, Cheshire, UK
Mid Cheshire Hospitals NHS Foundation Trust
Wed 10 10:10
FOE1.5
Defining the Future of Endocrinology: SfE Recommendations for Endocrine Services and Training in the Post-COVID NHS
Q&A
Leighton Hospital, Cheshire, UK
Homerton University Hospital, London, UK
Homerton University Hospital, London, UK
University of Sheffield, Sheffield, UK

Unknown speaker

Leighton Hospital, Cheshire, UK
Homerton University Hospital, London, UK
Homerton University Hospital, London, UK
University of Sheffield, Sheffield, UK
University of Birmingham, Birmingham, UK
Mid Cheshire Hospitals NHS Foundation Trust
Homerton University Hospital, London, UK
Homerton University Hospital, London, UK
University of Sheffield, Sheffield, UK
Dr Douglas Robertson
Leighton Hospital, Cheshire, UK
Wed 10 09:40
FOE1.2
Defining the Future of Endocrinology: SfE Recommendations for Endocrine Services and Training in the Post-COVID NHS
The Primary-Secondary Care Interface
Leighton Hospital, Cheshire, UK
Mid Cheshire Hospitals NHS Foundation Trust
Wed 10 10:10
FOE1.5
Defining the Future of Endocrinology: SfE Recommendations for Endocrine Services and Training in the Post-COVID NHS
Q&A
Leighton Hospital, Cheshire, UK
Homerton University Hospital, London, UK
Homerton University Hospital, London, UK
University of Sheffield, Sheffield, UK

Unknown speaker

Leighton Hospital, Cheshire, UK
Homerton University Hospital, London, UK
Homerton University Hospital, London, UK
University of Sheffield, Sheffield, UK
University of Birmingham, Birmingham, UK
Mid Cheshire Hospitals NHS Foundation Trust
Homerton University Hospital, London, UK
Homerton University Hospital, London, UK
University of Sheffield, Sheffield, UK
Douglas  Robertson
Mid Cheshire Hospitals NHS Foundation Trust
Wed 10 09:40
FOE1.2
Defining the Future of Endocrinology: SfE Recommendations for Endocrine Services and Training in the Post-COVID NHS
The Primary-Secondary Care Interface
Leighton Hospital, Cheshire, UK
Mid Cheshire Hospitals NHS Foundation Trust
Wed 10 10:10
FOE1.5
Defining the Future of Endocrinology: SfE Recommendations for Endocrine Services and Training in the Post-COVID NHS
Q&A
Leighton Hospital, Cheshire, UK
Homerton University Hospital, London, UK
Homerton University Hospital, London, UK
University of Sheffield, Sheffield, UK

Unknown speaker

Leighton Hospital, Cheshire, UK
Homerton University Hospital, London, UK
Homerton University Hospital, London, UK
University of Sheffield, Sheffield, UK
University of Birmingham, Birmingham, UK
Mid Cheshire Hospitals NHS Foundation Trust
Homerton University Hospital, London, UK
Homerton University Hospital, London, UK
University of Sheffield, Sheffield, UK
Cristina Ronchi
University of Birmingham, Birmingham, United Kingdom
Wed 10 10:35
S6.1
Symposium 6: Characterizing the Cortex to Improve Clinical Care
Single cell sequencing: lessons for the pathogenesis of adrenocortical tumours

Unknown speaker

University of Birmingham, Birmingham, United Kingdom
Professor Richard John M. Ross
Diurnal Ltd, Sheffield, UK
Tue 09 10:15
EC1.3
Early Careers and Plenary Orals
CET Best Clinical Abstract: Phase 3 and extension study of modified-release hydrocortisone in the treatment of congenital adrenal hyperplasia
Diurnal Ltd, Cardiff, United Kingdom
Diurnal Ltd, Sheffield, UK
Victoria Salem
Imperial College London, London, UK
Tue 09 14:54
OP4.4
Oral Posters 4 - Metabolism, Obesity and Diabetes
Audit of Clinical Outcomes with Dexamethasone in Patients Hospitalised with COVID-19
Imperial College London, London, UK
Dr Rocio Sancho
King's College London, London, UK
Tue 09 17:10
BPW2.1
Basic Physiology Workshop 2: Model Systems
Modelling diabetes using iPSCs and adult derived organoids
King's College London, London, UK
Kerstin Sander
University College London, London, UK
Tue 09 15:10
OC4.1
Oral Communications 4 - Adrenal and Cardiovascular
Development of [18F]AldoView as the first highly selective aldosterone synthase PET tracer for imaging of patients with Primary Hyperaldosteronism.
University College London, London, UK
Anna Scholz
Cardiff University, Cardiff, UK
Tue 09 16:10
OC6.5
Oral Communications 6 - Thyroid
Effects of in utero thyroid hormone exposure on human neurodevelopment: MRI analysis from the Controlled Antenatal Thyroid Screening Study
Cardiff University, Cardiff, UK
Dr Leighton Seal
St George's Hospital, London, UK
Wed 10 15:15
CMW2.2
Clinical Management Workshop 2: Widening perspective on reproductive health
Optimising health outcomes following gender reassignment
St George's Hospital, London, UK
Russell Senanayake
University of Cambridge, Cambridge, UK
Mon 08 13:20
OP2.1
Oral Posters 2 - Adrenal and Cardiovascular
A phase 1 clinical trial evaluating the safety and efficacy of up to two administrations of the adrenal PET tracer [18F]CETO in healthy volunteers and patients with primary aldosteronism
University of Cambridge, Cambridge, UK
Tue 09 15:40
OC4.3
Oral Communications 4 - Adrenal and Cardiovascular
[11C]Metomidate PET/CT can aid decision-making in patients with primary aldosteronism
University of Cambridge, Cambridge, UK
Professor  Patrick  Sexton
Monash Institute of Pharmaceutical Sciences, Melbourne, Australia
Mon 08 11:05
BPW1.1
Basic Physiology Workshop 1: New Techniques and Approaches
Applying cryo-EM to understanding the structure and dynamics of GPCRs
Monash Institute of Pharmaceutical Sciences, Melbourne, Australia
Ayesha Shaikh
Swansea Bay University Health Board, Swansea, UK
Mon 08 12:53
OP1.2
Oral Posters 1 - Thyroid
Long-term management of thyrotoxicosis with anti-thyroid drugs (ATDs)
Swansea Bay University Health Board, Swansea, UK
Professor Stephen  Shalet
The Christie NHS Foundation Trust, Manchester, UK
Wed 10 16:40
PL10
Plenary 10: Society for Endocrinology Jubilee Medal Lecture
Cancer Treatment Endocrinopathies and growth hormone status throughout life
The Christie NHS Foundation Trust, Manchester, UK
Dr  Omair Shariq
University of Oxford, Oxford, UK
Tue 09 11:30
S3.1
Symposium 3: Novel Approaches to the Diagnosis and Treatment of Endocrine Neoplasia
Diagnosis and management of MEN1 in childhood and adolescence
University of Oxford, Oxford, UK
Tue 09 12:30
S3.3
Symposium 3: Novel Approaches to the Diagnosis and Treatment of Endocrine Neoplasia
Discussion
University of Oxford, Oxford, UK
Imperial College London, London, UK
University of Oxford, Oxford, UK

Unknown speaker

University of Oxford, Oxford, UK
Imperial College London, London, UK
University of Oxford, Oxford, UK
MRC Laboratory of Medical Sciences, London, UK
Jian Shen Kiam
Norfolk and Norwich University Hospital, Norwich, UK
Wed 10 13:03
OP5.2
Oral Posters 5 - Bone and Calcium
Society for Endocrinology / Parathyroid UK National Hypoparathyroidism Management Audit
Norfolk and Norwich University Hospital, Norwich, UK
Lisa Shepherd
University of Birmingham, Birmingham, UK
Tue 09 15:55
NS2.3
Nurses' Session 2: Career Pathways in Endocrine Nursing: Entry points and Academic progression
An NIHR Fellowship
University of Birmingham, Birmingham, UK
Tue 09 16:15
NS2.4
Nurses' Session 2: Career Pathways in Endocrine Nursing: Entry points and Academic progression
Discussion
Oxford Centre for Diabetes, Endocrinology and Metabolism, Oxford, UK
Salford Royal NHS Foundation Trust, Salford, UK
London South Bank University, London, UK
University of Oxford Hospitals, Oxford, UK
University of Birmingham, Birmingham, UK
Helen Simpson
University College London Hospital, London, UK
Mon 08 12:05
HDI1.5
How Do I...?
How do I keep my patients with adrenal insufficiency safe?
University College London Hospital, London, UK
Tue 09 11:15
OCP1.2
Outstanding Clinical Practitioners Award
Patient safety - Shifting the paradigm
University College London Hospital, London, UK
Tue 09 17:10
NS3.1
Nurses' Session 3: Management of Endocrine Conditions in the time of COVID
Management of Hyponatraemia and Diabetes Insipidus
University College London Hospital, London, UK
Tue 09 17:10
NS3.3
Nurses' Session 3: Management of Endocrine Conditions in the time of COVID
Management of hyper- and hypo-thyroidism
University College London Hospital, London, UK
Tue 09 17:10
NS3.6
Nurses' Session 3: Management of Endocrine Conditions in the time of COVID
Management of Cushing’s syndrome
University College London Hospital, London, UK
Professor Lee Smith
University of Newcastle, New South Wales, Australia
Tue 09 12:30
S2.3
Symposium 2: Nuclear Receptors in Male Reproduction
Rapid gene therapy targeting of nuclear receptor pathways in the testis
University of Newcastle, New South Wales, Australia
Gabrielle Smith
Institute of Metabolism and System Research, Birmingham, UK
Tue 09 16:10
OC4.5
Oral Communications 4 - Adrenal and Cardiovascular
Circulating cell-free DNA-based biomarkers as a tool for disease surveillance in adrenocortical carcinoma
Institute of Metabolism and System Research, Birmingham, UK
Lewis Spencer
University of Derby, Derby, United Kingdom
Tue 09 14:38
OP4.2
Oral Posters 4 - Metabolism, Obesity and Diabetes
3mg Liraglutide ameliorates inflammation and improves hypothalamic regulation of energy homeostasis by modulation of Sphingosine-1-Phosphate signalling in super-responders
University of Derby, Derby, United Kingdom
Hannah Stephens
Imperial College London, London, UK
Tue 09 14:30
OP4.1
Oral Posters 4 - Metabolism, Obesity and Diabetes
Investigating the role of the gut metabolome in appetite and obesity
Imperial College London, London, UK
Professor Roland Stimson
University of Edinburgh, Edinburgh, UK
Mon 08 14:30
PL2
Plenary 2: Society for Endocrinology Starling Medal Lecture
Strategies to turn up the heat - investigating human brown adipose tissue function
University of Edinburgh, Edinburgh, UK
Dr Abd Tahrani
University of Birmingham, Birmingham, UK
Wed 10 12:10
MTE6
Meet the Expert 6 (Metabolism, Obesity and Diabetes)
Primary interventions in obesity and weight management
University of Birmingham, Birmingham, UK
Peter Taylor
Cardiff University, Cardiff, UK
Mon 08 12:45
OP1.1
Oral Posters 1 - Thyroid
Factors predicting long-term outcome and the need for surgery in Graves' Orbitopathy extended follow-up from the CIRTED Trial

Unknown speaker

Cardiff University, Cardiff, UK
Wed 10 14:10
Endocrine Network Session 8 - Thyroid
An overview of thyroid papers
University of Edinburgh, Edinburgh, UK

Unknown speaker

University of Edinburgh, Edinburgh, UK
Cardiff University, Cardiff, UK
Professor Roy Taylor
Newcastle University, Newcastle, UK
Tue 09 12:00
S1.2
Symposium 1: Lifestyle Hacks for Metabolic Disease
Remission possible, curing diabetes?
Newcastle University, Newcastle, UK
Peter Taylor
Cardiff University, Cardiff, UK
Mon 08 12:45
OP1.1
Oral Posters 1 - Thyroid
Factors predicting long-term outcome and the need for surgery in Graves' Orbitopathy extended follow-up from the CIRTED Trial

Unknown speaker

Cardiff University, Cardiff, UK
Wed 10 14:10
Endocrine Network Session 8 - Thyroid
An overview of thyroid papers
University of Edinburgh, Edinburgh, UK

Unknown speaker

University of Edinburgh, Edinburgh, UK
Cardiff University, Cardiff, UK
Raj Thakker
Oxford, United Kingdom
Mon 08
Welcome
President's Welcome to SfE BES 2021
Oxford, United Kingdom
Caitlin Thornton
University of Birmingham, Birmingham, UK
Tue 09 15:55
OC6.4
Oral Communications 6 - Thyroid
AP-2 and Moesin Regulate the Internalisation of the Sodium-Iodide Symporter and Affect I125 Uptake in Thyroid Cancer Cells.
University of Birmingham, Birmingham, UK
Layla Thurston
Imperial College London, London, UK
Mon 08 15:05
OC1.1
Oral Communications 1 - Reproductive and Neuroendocrinology
Melanocortin-4 receptor agonism improves sexual brain processing in women with low sexual desire
Imperial College London, London, UK
Jeremy Tomlinson
University of Oxford, Oxford, UK
Wed 10 16:10
PL9
Plenary 9: Society for Endocrinology Medal Lecture
Revisiting Cushing’s: The power of pre-receptor metabolism
University of Oxford, Oxford, UK
Jeremy Turner
Norfolk and Norwich University Hospital, Norfolk, UK
Wed 10 14:10
Endocrine Network Session 2 - Bone and Calcium
Updates and future plans for the Bone and Calcium network
Norfolk and Norwich University Hospital, Norfolk, UK
University of Birmingham, Birmingham, UK
Mark Turner
Coventry University, Coventry, UK
Wed 10 14:10
Endocrine Network Session 5 - Metabolism, Obesity and Diabetes
What skills, techniques and experience can you gain from visiting another laboratory
Coventry University, Coventry, UK
Thomas Upton
University of Bristol, Bristol, UK
Tue 09 15:55
OC4.4
Oral Communications 4 - Adrenal and Cardiovascular
24-hour dynamics of free tissue adrenal hormones: A description of healthy normal variation
University of Bristol, Bristol, UK
Dr Greet  Van den Berghe
Leuven University, Leuven, Belgium
Tue 09 18:45
PL6
Plenary 6: Society for Endocrinology European Medal Lecture
Rethinking critical illness-induced corticosteroid insufficiency
Leuven University, Leuven, Belgium
Dr Edward Visser
Erasmus Medical Center, Rotterdam, The Netherlands
Wed 10 11:35
S4.3
Symposium 4: Understanding Pathogenesis: Development of Novel Treatments
Translational Studies in Thyroid Hormone Transport
Erasmus Medical Center, Rotterdam, The Netherlands
Dr David Volle
GReD, Clermont-Ferrand, France
Tue 09 12:00
S2.2
Symposium 2: Nuclear Receptors in Male Reproduction
Bile acid metabolism & nuclear receptors in male reproduction
GReD, Clermont-Ferrand, France
Jennifer Walsh
Sheffield, UK
Mon 08 11:20
HDI1.2
How Do I...?
How do I investigate a young person with a low trauma fracture?
Sheffield, UK
Professor Martin Walz
University of Duidburg-Essen, Essen, Germany
Mon 08 18:15
D1.2
Debate: TO BLOCK, OR NOT TO BLOCK, THAT IS THE QUESTION: Controversies in peri-operative management of catecholamine producing tumours
Against the motion
University of Duidburg-Essen, Essen, Germany
Rongling Wang
University of Edinburgh, Edinburgh, UK
Mon 08 15:50
OC3.4
Oral Communications 3 - Metabolism, Obesity and Diabetes
Hepatic choline deficiency underpins amelioration of visceral obesity and diabetes in ectonucleotide pyrophosphatase (Enpp)-6–/–mice
University of Edinburgh, Edinburgh, UK
Emily Warmington
Institute of Metabolism and System Research, Birmingham, UK
Mon 08 13:36
OP2.3
Oral Posters 2 - Adrenal and Cardiovascular
PLK1 inhibitors as a new targeted treatment for adrenocortical carcinoma
Institute of Metabolism and System Research, Birmingham, UK
Thea L. Willis
King's College London, London, UK
Tue 09 14:19
OP3.4
Oral Posters 3 - Reproductive and Neuroendocrinology
Stem cell heterogeneity and regulation in the postnatal pituitary gland
King's College London, London, UK
Ms Ephia Yasmin
University College London Hospital, London, UK
Mon 08 11:35
HDI1.3
How Do I...?
How do I use AMH in clinical practice?
University College London Hospital, London, UK
Professor  Giles Yeo
University of Cambridge, Cambridge, UK
Mon 08 11:35
BPW1.2
Basic Physiology Workshop 1: New Techniques and Approaches
SC analysis and heterogeneity of hypothalamic neurons
University of Cambridge, Cambridge, UK
Dr Philip Yeoh
The London Clinic, London, UK
Tue 09 13:05
MTE7.1
Meet the Expert 7 (Nurse)
Hydrocortisone pump - Innovative practice across both NHS and Independent sector
The London Clinic, London, UK
Nicola Zammitt
Royal Infirmary of Edinburgh, Edinburgh, UK
Mon 08 12:20
HDI1.6
How Do I...?
How do I optimise thyroid status after RAI therapy?
Royal Infirmary of Edinburgh, Edinburgh, UK
Eder Zavala
University of Birmingham, Birmingham, UK
Mon 08 13:44
OP2.4
Oral Posters 2 - Adrenal and Cardiovascular
Modelling changes in the control, secretion and metabolism of cortisol during and after heart surgery.
University of Birmingham, Birmingham, UK
Maria-Christina  Zennaro
Université Paris Cité, Paris , France
Wed 10 11:05
S6.2
Symposium 6: Characterizing the Cortex to Improve Clinical Care
Hereditary Hyperaldosteronism

Unknown speaker

Université Paris Cité, Paris , France
Workshop 4
Mon 08 11:05
Clinical Management Workshop 1: Pituitary Challenges: Prompt, Practical and Post-op
Endocrinology, Diabetes & Metabolism Case Reports
Kilsyth & Moorfoot
Chairs: Dr Miles Levy (University Hospitals of Leicester, Leicester, UK) & Dr Rupa Ahluwalia (Norfolk and Norwich University Hospitals NHS Trust, Norfolk, UK)
Mon 08 11:05
CMW1.1
Clinical Management Workshop 1: Pituitary Challenges: Prompt, Practical and Post-op
Apoplexy
Birmingham, UK
Mon 08 11:35
CMW1.2
Clinical Management Workshop 1: Pituitary Challenges: Prompt, Practical and Post-op
Acute Cushing's
Guy's and St Thomas' Hospital, London, UK
Mon 08 12:05
CMW1.3
Clinical Management Workshop 1: Pituitary Challenges: Prompt, Practical and Post-op
Post op management
John Radcliffe Hospital, Oxford, UK
Mon 08 11:05
Basic Physiology Workshop 1: New Techniques and Approaches
Journal of Endocrinology
Sidlaw Auditorium
Chairs: Dr Jane Howard (Kings College London, London, UK) & Miss Hannah Stephens (Imperial College London, London, UK)
Mon 08 11:05
BPW1.1
Basic Physiology Workshop 1: New Techniques and Approaches
Applying cryo-EM to understanding the structure and dynamics of GPCRs
Monash Institute of Pharmaceutical Sciences, Melbourne, Australia
Mon 08 11:35
BPW1.2
Basic Physiology Workshop 1: New Techniques and Approaches
SC analysis and heterogeneity of hypothalamic neurons
University of Cambridge, Cambridge, UK
Mon 08 12:05
BPW1.3
Basic Physiology Workshop 1: New Techniques and Approaches
What you need to know about immunometabolism
Dresden University of Technology, Dresden, Germany
Tue 09 17:10
Basic Physiology Workshop 2: Model Systems
Sidlaw Auditorium
Chairs: Dr Andrew Childs (Imperial College London, London, UK) & Anastasia Tsakmaki (King’s College, London, UK)
Tue 09 17:10
BPW2.1
Basic Physiology Workshop 2: Model Systems
Modelling diabetes using iPSCs and adult derived organoids
King's College London, London, UK
Tue 09 17:40
BPW2.2
Basic Physiology Workshop 2: Model Systems
Ready Player One? 3D Gut endocrinology in a dish
King's College London, London, UK
Tue 09 18:10
BPW2.3
Basic Physiology Workshop 2: Model Systems
Organ on a Chip
Université de Genève, Brussels, Belgium
Wed 10 14:50
Clinical Management Workshop 2: Widening perspective on reproductive health
Turner Syndrome Support Society
Kilsyth & Moorfoot
Chairs: Dr Richard Quinton (Newcastle University, Newcastle, UK) & Channa Jayasena (Imperial College London, London, UK)
Wed 10 14:50
CMW2.1
Clinical Management Workshop 2: Widening perspective on reproductive health
Endometrial health - the role of the specialist menstrual disorders service
The University of Edinburgh, Edinburgh, UK
Wed 10 15:15
CMW2.2
Clinical Management Workshop 2: Widening perspective on reproductive health
Optimising health outcomes following gender reassignment
St George's Hospital, London, UK
Wed 10 15:40
CMW2.3
Clinical Management Workshop 2: Widening perspective on reproductive health
Healthy heart In Turner syndrome
Oxford, UK
Oral 12
Mon 08 12:45
Oral Posters 1 - Thyroid
Cromdale Hall
Chairs: Dr Carla Moran (Beacon Hospital, Dublin, Ireland) & Dr Anna Mitchell (Newcastle University, Newcastle, UK)
OP1
Mon 08 12:45
OP1.1
Oral Posters 1 - Thyroid
Factors predicting long-term outcome and the need for surgery in Graves' Orbitopathy extended follow-up from the CIRTED Trial

Unknown speaker

Cardiff University, Cardiff, UK
Mon 08 12:53
OP1.2
Oral Posters 1 - Thyroid
Long-term management of thyrotoxicosis with anti-thyroid drugs (ATDs)
Swansea Bay University Health Board, Swansea, UK
Mon 08 13:01
OP1.3
Oral Posters 1 - Thyroid
Thyroid Endocrine Nurse Service: Improving patient experience
Imperial College Healthcare NHS Trust, London, UK
Mon 08 13:09
OP1.4
Oral Posters 1 - Thyroid
Autoimmune thyrotoxicosis: is first line treatment with anti-thyroid medication good enough?
United Lincolnshire Hospitals NHS Trust, Lincoln, UK
Mon 08 13:20
Oral Posters 2 - Adrenal and Cardiovascular
Cromdale Hall
Chairs: Dr Scott MacKenzie (University of Glasgow, Glasgow, UK) & Dr Yasir Elhassan (Queen Elizabeth Hospital Birmingham, Birmingham, UK)
OP2
Mon 08 13:20
OP2.1
Oral Posters 2 - Adrenal and Cardiovascular
A phase 1 clinical trial evaluating the safety and efficacy of up to two administrations of the adrenal PET tracer [18F]CETO in healthy volunteers and patients with primary aldosteronism
University of Cambridge, Cambridge, UK
Mon 08 13:28
OP2.2
Oral Posters 2 - Adrenal and Cardiovascular
Single-centre analysis of 900 short synacthen tests: do pre-test clinical or biochemical variables predict failure?
Oxford Centre for Diabetes, Endocrinology and Metabolism, Oxford, UK
Mon 08 13:36
OP2.3
Oral Posters 2 - Adrenal and Cardiovascular
PLK1 inhibitors as a new targeted treatment for adrenocortical carcinoma
Institute of Metabolism and System Research, Birmingham, UK
Mon 08 13:44
OP2.4
Oral Posters 2 - Adrenal and Cardiovascular
Modelling changes in the control, secretion and metabolism of cortisol during and after heart surgery.
University of Birmingham, Birmingham, UK
Mon 08 15:05
Oral Communications 1 - Reproductive and Neuroendocrinology
Klinefelter's Syndrome Association
Pentland Auditorium
Chairs: Dr Bryn Owen (Imperial College London, London, UK) & Sijing Cheng (Imperial College London, London, UK)
OC1
Mon 08 15:05
OC1.1
Oral Communications 1 - Reproductive and Neuroendocrinology
Melanocortin-4 receptor agonism improves sexual brain processing in women with low sexual desire
Imperial College London, London, UK
Mon 08 15:20
OC1.2
Oral Communications 1 - Reproductive and Neuroendocrinology
Hyper-phosphorylation of β-catenin at Serine552 correlates with invasion and predicts recurrence of non-functioning pituitary tumours (NFPTs)
Queen Mary University of London, London, UK
Mon 08 15:35
OC1.3
Oral Communications 1 - Reproductive and Neuroendocrinology
Acromegalic cardiomyopathy in pituitary-specific aryl hydrocarbon receptor interacting protein (Aip) gene knockout animals

Unknown speaker

Queen Mary University of London, London, UK
Mon 08 15:50
OC1.4
Oral Communications 1 - Reproductive and Neuroendocrinology
Intranasal kisspeptin administration stimulates reproductive hormone secretion in healthy men
Imperial College London, London, UK
Mon 08 16:05
OC1.5
Oral Communications 1 - Reproductive and Neuroendocrinology
Is radiotherapy for pituitary adenoma or craniopharyngioma associated with increased risk of second brain tumour? A long-term multi-centre study of 3,679 patients
University of Birmingham, Birmingham, UK
Mon 08 16:20
OC1.6
Oral Communications 1 - Reproductive and Neuroendocrinology
Differential follicle stimulating hormone glycosylation modulates pre-antral follicle growth and survival rates

Unknown speaker

King's College London, London, UK
Mon 08 15:05
Oral Communications 2 - Endocrine Cancer and Late Effects
Sidlaw Auditorium
Chairs: Dr Paul Newey (University of Dundee, UK) & Dr Anna Mitchell (Newcastle University, Newcastle, UK)
OC2
Mon 08 15:05
OC2.1
Oral Communications 2 - Endocrine Cancer and Late Effects
Outcomes of surgery and treatment with selective RET TK inhibitor Selpercatinib in children with MEN2 and advanced MTC.

Unknown speaker

University College London Hospitals NHS Foundation Trust, London, UK
Mon 08 15:20
OC2.2
Oral Communications 2 - Endocrine Cancer and Late Effects
An emerging role for proteostasis modulators targeting NIS activity to enhance radioiodide therapy in thyroid cancer
University of Birmingham, Birmingham, UK
Mon 08 15:35
OC2.3
Oral Communications 2 - Endocrine Cancer and Late Effects
A novel in vivo platform for studying tumour vascularization and endocrine responses
Imperial College London, London, UK
Mon 08 15:50
OC2.4
Oral Communications 2 - Endocrine Cancer and Late Effects
PBF phosphorylation regulates cell motility of thyroid and breast cancer cells
University of Birmingham Institute of Metabolism and System Research, Birmingham, UK
Mon 08 16:05
OC2.5
Oral Communications 2 - Endocrine Cancer and Late Effects
A novel MiR-346-directed DNA damage mechanism is regulated by its interaction with long non-coding RNA, NORAD, in prostate cancer
Imperial College London, London, UK
Mon 08 16:20
OC2.6
Oral Communications 2 - Endocrine Cancer and Late Effects
Transcriptomic analysis of succinate dehydrogenase subunit deleted cells to identify molecular mechanisms underlying the increased metastatic potential of SDHB-deficient tumours
Queen Mary University of London, London, UK
Mon 08 15:05
Oral Communications 3 - Metabolism, Obesity and Diabetes
Kilsyth & Moorfoot
Chairs: Professor Sadaf Farooqi (University of Cambridge, Cambridge, UK) & Dr Chioma Izzi-Engbeaya (Imperial College London, London, UK)
OC3
Mon 08 15:05
OC3.1
Oral Communications 3 - Metabolism, Obesity and Diabetes
The serotonin transporter SLC6A4 protects human brown adipose tissue from serotonin-mediated suppression of thermogenesis
University of Edinburgh, Edinburgh, UK
Mon 08 15:20
OC3.2
Oral Communications 3 - Metabolism, Obesity and Diabetes
Comparing the transcriptional landscape between lean and obese mice within the small intestinal segments
King's College London, London, UK
Mon 08 15:35
OC3.3
Oral Communications 3 - Metabolism, Obesity and Diabetes
Sex-specific risk of obesity and cardiometabolic disease in low- and middle-income countries (LMICs): a meta-analysis in 681929 individuals
MRC Laboratory of Medical Sciences and Imperial College London, Birmingham, UK
Mon 08 15:50
OC3.4
Oral Communications 3 - Metabolism, Obesity and Diabetes
Hepatic choline deficiency underpins amelioration of visceral obesity and diabetes in ectonucleotide pyrophosphatase (Enpp)-6–/–mice
University of Edinburgh, Edinburgh, UK
Mon 08 16:05
OC3.5
Oral Communications 3 - Metabolism, Obesity and Diabetes
Microbial tryptophan metabolites modulate L-cell-induced GLP-1 secretion to improve glucose homeostasis
Imperial College London, London, UK
Mon 08 16:20
OC3.6
Oral Communications 3 - Metabolism, Obesity and Diabetes
Stimulation of motilin secretion by bile, free fatty acids and acidification in human duodenal organoids
Wellcome Trust, Cambridge, UK
Tue 09 13:55
Oral Posters 3 - Reproductive and Neuroendocrinology
Cromdale Hall
Chairs: Tatiana Lopes (Imperial College London, London, UK) & Dr Ali Abbara (Imperial College London, London, UK)
OP3
Tue 09 13:55
OP3.1
Oral Posters 3 - Reproductive and Neuroendocrinology
Discordant growth hormone and insulin like growth factor-1 values are associated with an increased mortality over concordant normal values in patients treated for acromegaly
Medical University of Gdansk, Gdansk, Poland
Tue 09 14:03
OP3.2
Oral Posters 3 - Reproductive and Neuroendocrinology
An ex-vivo human placental model demonstrates that temporal fluctuations in maternal glucose in gestational diabetes alter placental transcriptome networks associated vascular development and angiogenesis
University of Leeds, Leeds, UK
Tue 09 14:11
OP3.3
Oral Posters 3 - Reproductive and Neuroendocrinology
‘Suppression imaging’ – a novel PET technique for increasing confidence in the localisation of secretory pituitary microadenomas
University of Cambridge and Cambridge University Hospitals, Cambridge, UK
Tue 09 14:19
OP3.4
Oral Posters 3 - Reproductive and Neuroendocrinology
Stem cell heterogeneity and regulation in the postnatal pituitary gland
King's College London, London, UK
Tue 09 14:30
Oral Posters 4 - Metabolism, Obesity and Diabetes
Cromdale Hall
Chairs: Dr Abd Tahrani (University of Birmingham, Birmingham, UK) & Dr Patricia Thomas (University of Birmingham, Birmingham, UK)
OP4
Tue 09 14:30
OP4.1
Oral Posters 4 - Metabolism, Obesity and Diabetes
Investigating the role of the gut metabolome in appetite and obesity
Imperial College London, London, UK
Tue 09 14:38
OP4.2
Oral Posters 4 - Metabolism, Obesity and Diabetes
3mg Liraglutide ameliorates inflammation and improves hypothalamic regulation of energy homeostasis by modulation of Sphingosine-1-Phosphate signalling in super-responders
University of Derby, Derby, United Kingdom
Tue 09 14:46
OP4.3
Oral Posters 4 - Metabolism, Obesity and Diabetes
The Chemerin-CMKLR1 Axis is Functionally Important for Central Regulation of Energy Homeostasis
Nottingham Trent University, Nottingham, UK
Tue 09 14:54
OP4.4
Oral Posters 4 - Metabolism, Obesity and Diabetes
Audit of Clinical Outcomes with Dexamethasone in Patients Hospitalised with COVID-19
Imperial College London, London, UK
Tue 09 15:10
Oral Communications 4 - Adrenal and Cardiovascular
Pentland Auditorium
Chairs: Dr Cristina Ronchi (University of Birmingham, Birmingham, UK) & Dr Scott MacKenzie (University of Glasgow, Glasgow, UK)
OC4
Tue 09 15:10
OC4.1
Oral Communications 4 - Adrenal and Cardiovascular
Development of [18F]AldoView as the first highly selective aldosterone synthase PET tracer for imaging of patients with Primary Hyperaldosteronism.
University College London, London, UK
Tue 09 15:25
OC4.2
Oral Communications 4 - Adrenal and Cardiovascular
Somatic mutations of GNA11 and GNAQ in CTNNB1-mutant aldosterone-producing adenomas presenting in puberty, pregnancy or menopause.
Queen Mary University London, London, UK
Tue 09 15:40
OC4.3
Oral Communications 4 - Adrenal and Cardiovascular
[11C]Metomidate PET/CT can aid decision-making in patients with primary aldosteronism
University of Cambridge, Cambridge, UK
Tue 09 15:55
OC4.4
Oral Communications 4 - Adrenal and Cardiovascular
24-hour dynamics of free tissue adrenal hormones: A description of healthy normal variation
University of Bristol, Bristol, UK
Tue 09 16:10
OC4.5
Oral Communications 4 - Adrenal and Cardiovascular
Circulating cell-free DNA-based biomarkers as a tool for disease surveillance in adrenocortical carcinoma
Institute of Metabolism and System Research, Birmingham, UK
Tue 09 16:25
OC4.6
Oral Communications 4 - Adrenal and Cardiovascular
Glucocorticoids and the Vascular Molecular Clock : Implications in Vascular Function Control
Centre for Cardiovascular Science, Edinburgh, United Kingdom
Tue 09 15:10
Oral Communications 5 - Bone and Calcium
Kilsyth & Moorfoot
Chairs: Dr Zaki Hassan-Smith (University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK) & Dr Claire Higham (The Christie NHS Foundation Trust, Manchester, UK)
OC5
Tue 09 15:10
OC5.1
Oral Communications 5 - Bone and Calcium
Successful adeno-associated virus mediated neonatal gene therapy treatment of hypophosphatasia murine model resulted in bone maturation and increased survival to at least 18 months
Nippon Medical School, Tokyo, Japan
Tue 09 15:25
OC5.2
Oral Communications 5 - Bone and Calcium
Gastric inhibitory polypeptide (GIP) reduces human osteoclast activity by suppressing multiple signalling pathways
Odense University Hospital, Odense, Denmark
Tue 09 15:40
OC5.3
Oral Communications 5 - Bone and Calcium
Role of Intact and C-Terminal FGF-23 Assays in the Investigation of Metabolic Bone Disease.
Norfolk and Norwich University Hospitals NHS Foundation Trust, Norwich, UK
Tue 09 15:55
OC5.4
Oral Communications 5 - Bone and Calcium
Nuclear factor I/X (NFIX) regulates the transcriptional activity of the cellular retinoic acid binding protein 2 (CRABP2) promoter and altersCRABP2 expression in Marshall-Smith Syndrome (MSS) patients.
University of Oxford, Oxford, UK
Tue 09 16:10
OC5.5
Oral Communications 5 - Bone and Calcium
Diacylglycerol kinase delta haploinsufficiency in mice causes hypocalcaemia: relevance to human Autosomal Dominant Hypoclacemia (ADH)
University of Oxford, Oxford, UK
Tue 09 16:25
OC5.6
Oral Communications 5 - Bone and Calcium
The role of vitamin D supplementation in critically ill patients with COVID-19
Newcastle University, Newcastle, UK
Tue 09 15:10
Oral Communications 6 - Thyroid
Sidlaw Auditorium
Chairs: Professor Bijay Vaidya (Royal Devon and Exeter Hospital, Exeter, UK) & Dr Peter Taylor (Cardiff University, Cardiff, UK)
OC6
Tue 09 15:10
OC6.1
Oral Communications 6 - Thyroid
Adjuvant Rituximab – exploratory trial in young people with Graves’ disease
Newcastle, UK
Tue 09 15:25
OC6.2
Oral Communications 6 - Thyroid
Concerted action of TH transporters MCT8 and OATP1C1 regulates adult hippocampal neurogenesis and hippocampal function in mice
University of Duisburg-Essen, Essen, Germany
Tue 09 15:40
OC6.3
Oral Communications 6 - Thyroid
Failure of Radioiodine Remnant Ablation to Improve Postoperative Outcome in 2668 Adult Patients with AJCC/pTNM stage I Papillary Thyroid Carcinoma
Mayo Clinic, Rochester, MN, USA
Tue 09 15:55
OC6.4
Oral Communications 6 - Thyroid
AP-2 and Moesin Regulate the Internalisation of the Sodium-Iodide Symporter and Affect I125 Uptake in Thyroid Cancer Cells.
University of Birmingham, Birmingham, UK
Tue 09 16:10
OC6.5
Oral Communications 6 - Thyroid
Effects of in utero thyroid hormone exposure on human neurodevelopment: MRI analysis from the Controlled Antenatal Thyroid Screening Study
Cardiff University, Cardiff, UK
Tue 09 16:25
OC6.6
Oral Communications 6 - Thyroid
Forty years' experience of national screening programme for congenital hypothyroidism in Northern Ireland.
Queen's University Belfast, Belfast, UK
Royal Victoria Hospital, Belfast, UK
Wed 10 12:55
Oral Posters 5 - Bone and Calcium
Cromdale Hall
Chairs: Professor Rachel Crowley (St Vincent's University Hospital, Dublin, Ireland) & Dr Rowan Hardy (University of Birmingham, Birmingham, UK)
OP5
Wed 10 12:55
OP5.1
Oral Posters 5 - Bone and Calcium
Parathyroid hormone (PTH) of 1.6 pmol/L or more at 6 months is associated with delayed recovery of parathyroid function in post-surgical hypoparathyroidism (PoSH)
University of Sheffield, Sheffield, UK
Wed 10 13:03
OP5.2
Oral Posters 5 - Bone and Calcium
Society for Endocrinology / Parathyroid UK National Hypoparathyroidism Management Audit
Norfolk and Norwich University Hospital, Norwich, UK
Wed 10 13:11
OP5.3
Oral Posters 5 - Bone and Calcium
Vitamin D deficiency is highly prevalent among patients who died from COVID-19 in the North-East of England.
University of Newcastle, Newcastle, UK
Wed 10 13:19
OP5.4
Oral Posters 5 - Bone and Calcium
Normocalcaemic hyperparathyroidism: Impact of assay and reference range differences on the diagnosis
The Royal Wolverhampton NHS Trust, Wolverhampton, UK
Wed 10 13:30
Oral Posters 6 - Endocrine Cancer and Late Effects
Cromdale Hall
Chair: Dr Safwaan Adam (The Christie Hospital, Manchester, UK) and Dr Ahmed Al-Qaissi (Leeds Teaching Hospitals NHS Trust, Leeds, UK)
OP6
Wed 10 13:30
OP6.1
Oral Posters 6 - Endocrine Cancer and Late Effects
Incidental findings are common, but rarely clinically significant, in patients with Neuroendocrine Tumours undergoing Gallium68 Dotatate PET CT; results from a one year retrospective review
Oxford Centre for Diabetes, Endocrinology and Metabolism, Oxford, UK
Wed 10 13:38
OP6.2
Oral Posters 6 - Endocrine Cancer and Late Effects
The evaluation of a musculoskeletal health package intervention to prevent bone toxicity in women with gynaecological malignancies undergoing pelvic radiotherapy. The RadBone randomised controlled feasibility study.
Christie Hospital NHS Foundation Trust, Manchester, UK
Wed 10 13:46
OP6.3
Oral Posters 6 - Endocrine Cancer and Late Effects
An unusual presentation of hypoglycaemia: An investigative challenge
Imperial College London, London, UK
Wed 10 13:54
OP6.4
Oral Posters 6 - Endocrine Cancer and Late Effects
Virtual Blood Pressure Monitoring in the Pre-operative Management of Phaeochromocytoma Patients in a Tertiary Centre during the COVID-19 Pandemic
The Christie NHS Foundation Trust, Manchester, UK
Expert 7
Tue 09 13:05
Meet the Expert 1 (Adrenal and Cardiovascular)
Pentland Auditorium
Chair: Dr Yasir Elhassan (University of Birmingham, Birmingham, UK)
Tue 09 13:05
MTE1
Meet the Expert 1 (Adrenal and Cardiovascular)
Preconception in pregnancy care in CAH
Munich, Germany
Tue 09 13:05
Meet the Expert 2 (Bone and Calcium)
Kilsyth & Moorfoot
Chair: Dr Jennifer Walsh (The University of Sheffield, Sheffield, UK)
Tue 09 13:05
MTE2
Meet the Expert 2 (Bone and Calcium)
Measuring bone markers
Northern General Hospital, Sheffield, UK
Tue 09 13:05
Meet the Expert 3 (Thyroid)
British Thyroid Foundation
Sidlaw Auditorium
Chair: Dr Nicola Zammitt (Edinburgh Centre for Endocrinology and Diabetes, Edinburgh, UK)
Tue 09 13:05
MTE3
Meet the Expert 3 (Thyroid)
Thyroid disease assessment and management; controversies in the NICE guidelines
University of Birmingham, Birmingham, UK
Tue 09 13:05
Meet the Expert 7 (Nurse)
Tinto
Chair: Lisa Shepherd (Birmingham Heartlands Hospital, Birmingham, UK)
Tue 09 13:05
MTE7.1
Meet the Expert 7 (Nurse)
Hydrocortisone pump - Innovative practice across both NHS and Independent sector
The London Clinic, London, UK
Tue 09 13:05
MTE7.2
Meet the Expert 7 (Nurse)
How adolescent care is different to adults or children
Guy's and St. Thomas' NHS Foundation Trust, London, UK
Wed 10 12:10
Meet the Expert 4 (Endocrine Cancer and Late Effects)
Probe or Palpate? What is the Optimum Long Term Thyroid Surveillance in Cancer Survivors?
Sidlaw Auditorium
Chair: Dr Helen Simpson (University College London Hospital, London, UK)
Wed 10 12:10
MTE4
Meet the Expert 4 (Endocrine Cancer and Late Effects)
Thyroid surveillance after radiotherapy
Memorial Sloane Kettering Cancer center, New York, USA
Wed 10 12:10
Meet the Expert 5 (Reproductive and Neuroendocrinology)
Pentland Auditorium
Chair: Dr Annice Mukherjee (Spire Manchester Hospital, Manchester, UK)
Wed 10 12:10
MTE5
Meet the Expert 5 (Reproductive and Neuroendocrinology)
I want KNDy: What's New in Flushing and Fertility?
London, UK
Wed 10 12:10
Meet the Expert 6 (Metabolism, Obesity and Diabetes)
Klinefelter's Syndrome Association
Kilsyth & Moorfoot
Chair: Professor Jeremy Tomlinson (University of Oxford, Oxford, UK)
Wed 10 12:10
MTE6
Meet the Expert 6 (Metabolism, Obesity and Diabetes)
Primary interventions in obesity and weight management
University of Birmingham, Birmingham, UK
Plenary 11
Mon 08 10:15
SfE BES 75th Anniversary Lecture
Pentland Auditorium
Chair: Professor Rajesh Thakker (University of Oxford, Oxford, UK)
Mon 08 10:15
AN1
SfE BES 75th Anniversary Lecture
Discovery of a new hormone, leptin, and its roles in health and disease
Rockefeller University, New York, USA
Mon 08 14:00
Plenary 1: British Thyroid Association Pitt-Rivers Lecture
British Thyroid Association
Pentland Auditorium
Chair: Professor Simon Pearce (Newcastle University, Newcastle, UK)
PL1
Mon 08 14:00
PL1
Plenary 1: British Thyroid Association Pitt-Rivers Lecture
Role of thyroid hormone transporters in brain development and function
Essen, Germany
Mon 08 14:30
Plenary 2: Society for Endocrinology Starling Medal Lecture
Society for Endocrinology
Pentland Auditorium
Chair: Professor Eleanor Davies (University of Glasgow, Glasgow, UK)
PL2
Mon 08 14:30
PL2
Plenary 2: Society for Endocrinology Starling Medal Lecture
Strategies to turn up the heat - investigating human brown adipose tissue function
University of Edinburgh, Edinburgh, UK
Mon 08 17:45
Plenary 3: Society for Endocrinology Dale Medal Lecture
Society for Endocrinology
Pentland Auditorium
Chair: Professor Mark Gurnell (University of Cambridge, Cambridge, UK)
PL3
Mon 08 17:45
PL3
Plenary 3: Society for Endocrinology Dale Medal Lecture
The biology of weight regulation
MRC Institute of Metabolic Science, Cambridge, UK
Tue 09 08:30
Plenary 4: Society for Endocrinology Transatlantic Medal Lecture
Society for Endocrinology
Pentland Auditorium
Chair: Professor Duncan Bassett (Imperial College London, London, UK)
PL4
Tue 09 08:30
PL4
Plenary 4: Society for Endocrinology Transatlantic Medal Lecture
Feast and famine: nuclear receptor control of liver energy balance
University of California, California, USA
Tue 09 09:00
Plenary 5: Society for Endocrinology International Medal Lecture
Society for Endocrinology
Pentland Auditorium
Chair: Professor Robert Semple (University of Edinburgh, Edinburgh, UK)
PL5
Tue 09 09:00
PL5
Plenary 5: Society for Endocrinology International Medal Lecture
Activation of the gp130 receptor: a panacea for the treatment of metabolic diseases?
Monash University, Melbourne, Australia
Tue 09 18:45
Plenary 6: Society for Endocrinology European Medal Lecture
Pentland Auditorium
Chair: Professor Eleanor Davies (University of Glasgow, Glasgow, UK)
PL6
Tue 09 18:45
PL6
Plenary 6: Society for Endocrinology European Medal Lecture
Rethinking critical illness-induced corticosteroid insufficiency
Leuven University, Leuven, Belgium
Wed 10 08:30
Plenary 7: Clinical Endocrinology Trust Lecture
Clinical Endocrinology Trust
Pentland Auditorium
Chair: Professor Aled Rees (Cardiff University, Cardiff, UK)
PL7
Wed 10 08:30
PL7
Plenary 7: Clinical Endocrinology Trust Lecture
The yin and yang of hormones and glucose

Unknown speaker

London, London, UK
Wed 10 09:00
Plenary 8: CET Visiting Professor Lecture
Clinical Endocrinology Trust
Pentland Auditorium
Chair: Professor Maralyn Druce (Barts Health NHS Trust, London, UK)
PL8
Wed 10 09:00
PL8
Plenary 8: CET Visiting Professor Lecture
Enigma of the Adrenal SHH Progenitor
University of Michigan, Michigan, USA
Wed 10 16:10
Plenary 9: Society for Endocrinology Medal Lecture
Society for Endocrinology
Pentland Auditorium
Chair: Professor Ruth Andrew (The University of Edinburgh, Edinburgh, UK)
PL9
Wed 10 16:10
PL9
Plenary 9: Society for Endocrinology Medal Lecture
Revisiting Cushing’s: The power of pre-receptor metabolism
University of Oxford, Oxford, UK
Wed 10 16:40
Plenary 10: Society for Endocrinology Jubilee Medal Lecture
Society for Endocrinology
Pentland Auditorium
Chair: Professor Mark Gurnell (University of Cambridge, Cambridge, UK)
PL10
Wed 10 16:40
PL10
Plenary 10: Society for Endocrinology Jubilee Medal Lecture
Cancer Treatment Endocrinopathies and growth hormone status throughout life
The Christie NHS Foundation Trust, Manchester, UK
Catering and Social 10
Mon 08 12:35
LUNCH, EXHIBITION, SATELLITES AND POSTERS
Lennox Suite & Concourse
Mon 08 16:35
TEA & COFFEE
Lennox Suite
Mon 08 19:00
Presidential Welcome Reception
Lennox Suite
Mon 08 19:30
Early Career Dinner & Quiz
Cromdale Hall
Tue 09 10:35
TEA & COFFEE
Lennox Suite
Tue 09 13:50
LUNCH, EXHIBITION, SATELLITES AND POSTERS
Lennox Suite & Concourse
Tue 09 16:40
TEA & COFFEE
Lennox Suite
Tue 09 20:00
Conference Dinner
National Museum of Scotland
Wed 10 10:20
TEA & COFFEE
Lennox Suite
Wed 10 12:55
LUNCH, EXHIBITION, SATELLITES AND POSTERS
Lennox Suite
Nurse 3
Tue 09 11:30
Nurses' Session 1: Acromegaly
The Pituitary Foundation
Tinto
Chairs: Sherwin Criseno (University Hospitals Birmingham, Birmingham, UK) & Aldons Chua (East Sussex Healthcare NHS Trust, East Sussex, UK)
NS1
Tue 09 11:30
NS1.1
Nurses' Session 1: Acromegaly
Advances in the management of Acromegaly 2021
St James’s Hospital, Leeds, UK
Tue 09 12:00
NS1.2
Nurses' Session 1: Acromegaly
Biochemical cure – is this enough?
Birmingham, UK
Tue 09 12:30
NS1.3
Nurses' Session 1: Acromegaly
Addressing the unmet psychosocial needs of patients with treated Acromegaly
The Pituitary Foundation, Bristol, UK
Tue 09 15:10
Nurses' Session 2: Career Pathways in Endocrine Nursing: Entry points and Academic progression
Neuroendocrine Cancer UK
Tinto
Chairs: Anne Marland (Oxford Centre for Diabetes, Endocrinology and Metabolism, Oxford, UK) & Kathryn Kinsella (Salford Royal NHS Foundation Trust, Salford, UK)
NS2
Tue 09 15:10
NS2.1
Nurses' Session 2: Career Pathways in Endocrine Nursing: Entry points and Academic progression
Advanced Practice and Prescribing
UK
Tue 09 15:30
NS2.2
Nurses' Session 2: Career Pathways in Endocrine Nursing: Entry points and Academic progression
Graduate Experience – Masters Module in Endocrine Nursing
University of Oxford Hospitals, Oxford, UK
Tue 09 15:55
NS2.3
Nurses' Session 2: Career Pathways in Endocrine Nursing: Entry points and Academic progression
An NIHR Fellowship
University of Birmingham, Birmingham, UK
Tue 09 16:15
NS2.4
Nurses' Session 2: Career Pathways in Endocrine Nursing: Entry points and Academic progression
Discussion
Oxford Centre for Diabetes, Endocrinology and Metabolism, Oxford, UK
Salford Royal NHS Foundation Trust, Salford, UK
London South Bank University, London, UK
University of Oxford Hospitals, Oxford, UK
University of Birmingham, Birmingham, UK
Tue 09 17:10
Nurses' Session 3: Management of Endocrine Conditions in the time of COVID
Tinto
Chairs: Miriam Asia (University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK) & Allan Davasgaium (University Hospitals Coventry & Warwickshire NHS Trust, Coventry, UK)
Tue 09 17:10
NS3.1
Nurses' Session 3: Management of Endocrine Conditions in the time of COVID
Management of Hyponatraemia and Diabetes Insipidus
University College London Hospital, London, UK
Tue 09 17:10
NS3.2
Nurses' Session 3: Management of Endocrine Conditions in the time of COVID
Management of adrenal insufficiency
University Hospitals Birmingham, Birmingham, UK
Tue 09 17:10
NS3.3
Nurses' Session 3: Management of Endocrine Conditions in the time of COVID
Management of hyper- and hypo-thyroidism
University College London Hospital, London, UK
Tue 09 17:10
NS3.4
Nurses' Session 3: Management of Endocrine Conditions in the time of COVID
Management of pituitary tumours
University Hospitals Birmingham, Birmingham, UK
Tue 09 17:10
NS3.5
Nurses' Session 3: Management of Endocrine Conditions in the time of COVID
Management of calcium disorders and osteoporosis
University Hospitals Birmingham, Birmingham, UK
Tue 09 17:10
NS3.6
Nurses' Session 3: Management of Endocrine Conditions in the time of COVID
Management of Cushing’s syndrome
University College London Hospital, London, UK
Other 3
Mon 08 11:05
How Do I...?
Addison's Disease Self-Help Group
Pentland Auditorium
Chairs: Dr Annice Mukherjee (Spire Manchester Hospital, Manchester, UK) & Dr Afroze Abbas (University of Leeds, Leeds, UK)
Mon 08 11:05
HDI1.1
How Do I...?
How should I investigate for effect of radiotherapy on the hypothalamus and pituitary?

Unknown speaker

The Christie NHS Foundation Trust, Manchester, UK
Mon 08 11:20
HDI1.2
How Do I...?
How do I investigate a young person with a low trauma fracture?
Sheffield, UK
Mon 08 11:35
HDI1.3
How Do I...?
How do I use AMH in clinical practice?
University College London Hospital, London, UK
Mon 08 11:50
HDI1.4
How Do I...?
How do I screen an SDH gene carrier?

Unknown speaker

Cambridge University Hospital NHS Foundation Trust, Cambridge, United Kingdom
Mon 08 12:05
HDI1.5
How Do I...?
How do I keep my patients with adrenal insufficiency safe?
University College London Hospital, London, UK
Mon 08 12:20
HDI1.6
How Do I...?
How do I optimise thyroid status after RAI therapy?
Royal Infirmary of Edinburgh, Edinburgh, UK
Tue 09 19:15
Society for Endocrinology AGM - members only
Pentland Auditorium
Wed 10 17:10
Prizes and Awards
Pentland Auditorium
Symposium 5
Tue 09 11:30
Symposium 2: Nuclear Receptors in Male Reproduction
Journal of Molecular Endocrinology
Pentland Auditorium
Chairs: Dr Douglas Gibson (University of Edinburgh, UK) & Dr Kim Jonas (King's College London, London, UK)
Tue 09 11:30
S2.1
Symposium 2: Nuclear Receptors in Male Reproduction
LXR and testicular function
Imperial College London, London, UK
Tue 09 12:00
S2.2
Symposium 2: Nuclear Receptors in Male Reproduction
Bile acid metabolism & nuclear receptors in male reproduction
GReD, Clermont-Ferrand, France
Tue 09 12:30
S2.3
Symposium 2: Nuclear Receptors in Male Reproduction
Rapid gene therapy targeting of nuclear receptor pathways in the testis
University of Newcastle, New South Wales, Australia
Tue 09 11:30
Symposium 3: Novel Approaches to the Diagnosis and Treatment of Endocrine Neoplasia
AMEND
Sidlaw Auditorium
Chairs: Dr Kate Lines (Oxford University, Oxford, UK) & Dr Claire Fletcher (Imperial College London, London, UK)
Tue 09 11:30
S3.1
Symposium 3: Novel Approaches to the Diagnosis and Treatment of Endocrine Neoplasia
Diagnosis and management of MEN1 in childhood and adolescence
University of Oxford, Oxford, UK
Tue 09 12:00
S3.2
Symposium 3: Novel Approaches to the Diagnosis and Treatment of Endocrine Neoplasia
Advances in diagnostics for ACC-a multiomics approach
MRC Laboratory of Medical Sciences, London, UK
Tue 09 12:30
S3.3
Symposium 3: Novel Approaches to the Diagnosis and Treatment of Endocrine Neoplasia
Discussion
University of Oxford, Oxford, UK
Imperial College London, London, UK
University of Oxford, Oxford, UK

Unknown speaker

University of Oxford, Oxford, UK
Imperial College London, London, UK
University of Oxford, Oxford, UK
MRC Laboratory of Medical Sciences, London, UK
Wed 10 10:35
Symposium 4: Understanding Pathogenesis: Development of Novel Treatments
Sidlaw Auditorium
Chairs: Dr Colin Dayan (Cardiff University, Cardiff, UK) & Dr Catherine Napier (Newcastle University, Newcastle, UK)
Wed 10 10:35
S4.1
Symposium 4: Understanding Pathogenesis: Development of Novel Treatments
Graves' disease
Newcastle University, Newcastle, UK
Wed 10 11:05
S4.2
Symposium 4: Understanding Pathogenesis: Development of Novel Treatments
Thyroid Eye Disease
Johannes Gutenberg University Medical Center, Mianz, Germany
Wed 10 11:35
S4.3
Symposium 4: Understanding Pathogenesis: Development of Novel Treatments
Translational Studies in Thyroid Hormone Transport
Erasmus Medical Center, Rotterdam, The Netherlands
Wed 10 10:35
Symposium 5: What is New in Calcium and Bone
Journal of Molecular Endocrinology
Kilsyth & Moorfoot
Chairs: Dr Caroline Gorvin (University of Birmingham, Birmingham, UK) & Dr Rachel Crowley (St Vincent’s Private Hospital, Dublin, Ireland)
Wed 10 10:35
S5.1
Symposium 5: What is New in Calcium and Bone
Osteomorphs: a newcell entity regulating bone resorption
Garvan Institute of Medical Research, Sydney, Australia
Wed 10 11:05
S5.2
Symposium 5: What is New in Calcium and Bone
Location Bias in cAMP and PTHR Biology
University of Pittsburgh, Pittsburgh, USA
Wed 10 11:35
S5.3
Symposium 5: What is New in Calcium and Bone
Targeting the Calcium-Sensing Receptor
National Institute of Dental and Craniofacial Research, Bethesda MD, USA
Wed 10 10:35
Symposium 6: Characterizing the Cortex to Improve Clinical Care
Pentland Auditorium
Chairs: Dr Russell Senanayake (University of Cambridge, Cambridge, UK) & Dr Miguel De Bono (Sheffield Teaching Hospitals, Sheffield, UK)
Wed 10 10:35
S6.1
Symposium 6: Characterizing the Cortex to Improve Clinical Care
Single cell sequencing: lessons for the pathogenesis of adrenocortical tumours

Unknown speaker

University of Birmingham, Birmingham, United Kingdom
Wed 10 11:05
S6.2
Symposium 6: Characterizing the Cortex to Improve Clinical Care
Hereditary Hyperaldosteronism

Unknown speaker

Université Paris Cité, Paris , France
Wed 10 11:35
S6.3
Symposium 6: Characterizing the Cortex to Improve Clinical Care
CT characteristics of adrenal nodules to guide management
Mayo Clinic, Minnesota, USA
No Session Type 35
Mon 08 08:30
Registration
Strathblane Hall
Mon 08 09:30
Welcome
Pentland Auditorium
Mon 08
Welcome
President's Welcome to SfE BES 2021
Oxford, United Kingdom
Mon 08 09:45
What is New?
Journal of Endocrinology
Pentland Auditorium
Chair: Professor Duncan Bassett (Imperial College, London, UK)
WIN
Mon 08 09:45
WIN1
What is New?
What is New in Basic Endocrinology Research?
Imperial College London, London, United Kingdom
Mon 08 10:00
WIN2
What is New?
What is New in Clinical Endocrinology Research?
Barts Health NHS Trust, London, UK
Mon 08 12:55
INDUSTRY-SPONSORED SATELLITE SYMPOSIA - (Please see Sponsored Satellite Symposia programme for more information)
Kilsyth & Moorfoot
Mon 08 12:55
INDUSTRY-SPONSORED SATELLITE SYMPOSIA - (Please see Sponsored Satellite Symposia programme for more information)
Sidlaw Auditorium
Mon 08 17:00
Presidential Lecture
Society for Endocrinology
Pentland Auditorium
Chair: Professor Rajesh Thakker (University of Oxford, Oxford, UK)
Mon 08 17:00
PR1
Presidential Lecture
Elucidation of cellular oxygen sensing mechanisms: implications for medicine
Nuffield Department of Medicine, Oxford, UK
Mon 08 18:15
Debate: TO BLOCK, OR NOT TO BLOCK, THAT IS THE QUESTION: Controversies in peri-operative management of catecholamine producing tumours
Motion: This house believes that α-blockade is essential for phaeochromocytoma surgery
Endocrine-Related Cancer
Pentland Auditorium
Chair: Dr Ruth Casey (Cambridge University Hospital NHS Foundation Trust, Cambridge, UK)
D1
Mon 08 18:15
D1.1
Debate: TO BLOCK, OR NOT TO BLOCK, THAT IS THE QUESTION: Controversies in peri-operative management of catecholamine producing tumours
For the motion
St Bartholomew’s Hospital, London, UK
Mon 08 18:15
D1.2
Debate: TO BLOCK, OR NOT TO BLOCK, THAT IS THE QUESTION: Controversies in peri-operative management of catecholamine producing tumours
Against the motion
University of Duidburg-Essen, Essen, Germany
Tue 09 07:00
Registration
Strathblane Hall
Tue 09 07:40
The New SfE Androgen Replacement Guidelines
Pentland Auditorium
Chairs: Dr Richard Quinton (Newcastle University, Newcastle, UK) & Dr Channa Jayasena (Imperial College London, London, UK)
Tue 09 07:40
ARG1.1
The New SfE Androgen Replacement Guidelines
Androgen replacement in men: Classification, diagnosis and biochemical assessment
Imperial College London, London, UK
Tue 09 08:00
ARG1.2
The New SfE Androgen Replacement Guidelines
Changes to safety monitoring for androgen replacement in men
Imperial College London, London, UK
Tue 09 09:35
Early Careers and Plenary Orals
Clinical Endocrinology Trust
Pentland Auditorium
Chairs: Professor Maralyn Druce (Barts Health NHS Trust, London, UK) & Professor Kevin Murphy (Imperial College London, London, UK) & Dr Helen Turner (Oxford University Hospitals NHS Foundation Trust, Oxford, UK)
Tue 09 09:35
EC1.1
Early Careers and Plenary Orals
Early Career Prize Lecture Basic Science: Using gene discovery to identify new key regulators of beta cell development
University of Exeter, Exeter, UK
Tue 09 09:55
EC1.2
Early Careers and Plenary Orals
Early Career Prize Lecture Clinical: Cardiometabolic disease burden and urine steroid metabolome in benign adrenocortical tumours: a case-control study
University of Birmingham, Birmingham, UK
Tue 09 10:15
EC1.3
Early Careers and Plenary Orals
CET Best Clinical Abstract: Phase 3 and extension study of modified-release hydrocortisone in the treatment of congenital adrenal hyperplasia
Diurnal Ltd, Cardiff, United Kingdom
Diurnal Ltd, Sheffield, UK
Tue 09 10:25
EC1.4
Early Careers and Plenary Orals
CET Best Basic Abstract: The vagal calcium sensing receptor mediates the effect of protein ingestion on insulin release and regulates macronutrient metabolism
Imperial College London, London, UK
Tue 09 11:00
Teaching Achievement Award
Pentland Auditorium
Chair: Professor Eleanor Davies (University of Glasgow, Glasgow, UK)
Tue 09 11:00
TAA1
Teaching Achievement Award
Teaching fertile minds- seeking out teaching opportunities during clinical training
Imperial College London, London, UK
Tue 09 11:15
TAA2
Teaching Achievement Award
Developing a Career in Education
Imperial College London, London, UK
Tue 09 11:00
Outstanding Clinical Practitioners Award
Sidlaw Auditorium
Chairs: Dr Paul Carroll (Guy's & St. Thomas' NHS Foundation Trust, London, UK)
Tue 09 11:00
OCP1.1
Outstanding Clinical Practitioners Award
Improving the care of patients with thyroid diseases
University of Birmingham, Birmingham, UK
Tue 09 11:15
OCP1.2
Outstanding Clinical Practitioners Award
Patient safety - Shifting the paradigm
University College London Hospital, London, UK
Tue 09 11:00
Endocrine Nurse Award & Nikki Kieffer Medal
Tinto
Chair: Phillip Yeoh (The London Clinic, London, UK)
Tue 09 11:00
ENA1
Endocrine Nurse Award & Nikki Kieffer Medal
Endocrine Nurse Award 2020
University Hospitals Birmingham, Birmingham, UK
Tue 09 11:15
NKM1
Endocrine Nurse Award & Nikki Kieffer Medal
Nikki Kieffer Medal
Oxford Centre for Diabetes, Endocrinology and Metabolism, Oxford, UK
Tue 09 11:30
Symposium 1: Lifestyle Hacks for Metabolic Disease
Endocrine Connections
Kilsyth & Moorfoot
Chairs: Professor Barbara McGowan (St Thomas’s Hospital, London, UK) & Dr Chioma Izzi-Engbeaya (Imperial College London, London, UK)
Tue 09 11:30
S1.1
Symposium 1: Lifestyle Hacks for Metabolic Disease
When not to eat; from mice to men
University of Utah, Utah, USA
Tue 09 12:00
S1.2
Symposium 1: Lifestyle Hacks for Metabolic Disease
Remission possible, curing diabetes?
Newcastle University, Newcastle, UK
Tue 09 12:30
S1.3
Symposium 1: Lifestyle Hacks for Metabolic Disease
A new era in gut-hormone based pharmacotherapy for people with obesity?
University College London, London, UK
Tue 09 14:05
INDUSTRY-SPONSORED SATELLITE SYMPOSIA - (Please see Sponsored Satellite Symposia programme for more information)
Kilsyth & Moorfoot
Tue 09 14:05
INDUSTRY-SPONSORED SATELLITE SYMPOSIA - (Please see Sponsored Satellite Symposia programme for more information)
Sidlaw Auditorium
Tue 09 17:10
How Do I...? 2
Pentland Auditorium
Chairs: Dr Antonia Brooke (Royal Devon and Exeter Hospital, Exeter, UK) & Dr Azmi Mohammed (County Durham and Darlington NHS Foundation Trust, UK)
Tue 09 17:10
HDI2.1
How Do I...? 2
How do I investigate abnormal alkaline phosphatase and bone context?
St Vincent's University Hospital, Dublin, Ireland
Tue 09 17:25
HDI2.2
How Do I...? 2
How do I diagnose and manage a low testosterone in men with obesity?
Imperial College London, London, UK
Tue 09 17:40
HDI2.3
How Do I...? 2
How do I manage pituitary macroadenoma in pregnancy?
The University of Edinburgh, Edinburgh, UK
Tue 09 17:55
HDI2.4
How Do I...? 2
How do I screen for cardiovascular effects of cancer treatments?
University College London Hospital, London, UK
Tue 09 18:10
HDI2.5
How Do I...? 2
How do I confirm biochemical diagnosis of primary aldosteronism?
Queen Elizabeth University Hospital, Glasgow, UK
Tue 09 18:25
HDI2.6
How Do I...? 2
How do I approach isolated hypothyroxinaemia?
Beacon Hospital and University College Dublin, Dublin, Ireland
Tue 09 17:10
Senior Endocrinologists' Session
Kilsyth & Moorfoot
Chairs: Dr Ian Mason (The University of Edinburgh, Edinburgh, UK) & Professor Adrian Clark (St Bartholomew's Hospital, London, UK)
Tue 09 17:10
SE1.1
Senior Endocrinologists' Session
Are gonadotrophins more than gonadotrophins?
Imperial College London, London, UK
Tue 09 17:40
SE1.2
Senior Endocrinologists' Session
What in the World is EIS?
National Institute of Environmental Health Sciences, Durham, USA
Tue 09 18:10
SE1.3
Senior Endocrinologists' Session
INSL3: a new index of testis function in puberty and aging
University of Nottingham, Nottingham , UK
Wed 10 07:30
Registration
Strathblane Hall
Wed 10 09:35
Defining the Future of Endocrinology: SfE Recommendations for Endocrine Services and Training in the Post-COVID NHS
Pentland Auditorium
Chairs: Professor John Newell-Price (University of Sheffield, Sheffield, UK) & Professor Kristien Boelaert (University of Birmingham, Birmingham, UK)
Wed 10 09:35
FOE1.1
Defining the Future of Endocrinology: SfE Recommendations for Endocrine Services and Training in the Post-COVID NHS
Introduction
University of Sheffield, Sheffield, UK
University of Birmingham, Birmingham, UK
Wed 10 09:40
FOE1.2
Defining the Future of Endocrinology: SfE Recommendations for Endocrine Services and Training in the Post-COVID NHS
The Primary-Secondary Care Interface
Leighton Hospital, Cheshire, UK
Mid Cheshire Hospitals NHS Foundation Trust
Wed 10 09:50
FOE1.3
Defining the Future of Endocrinology: SfE Recommendations for Endocrine Services and Training in the Post-COVID NHS
Enhancing and Protecting Training
Homerton University Hospital, London, UK
Wed 10 10:00
FOE1.4
Defining the Future of Endocrinology: SfE Recommendations for Endocrine Services and Training in the Post-COVID NHS
The Society for Endocrinology Resource Hub
Homerton University Hospital, London, UK
Wed 10 10:10
FOE1.5
Defining the Future of Endocrinology: SfE Recommendations for Endocrine Services and Training in the Post-COVID NHS
Q&A
Leighton Hospital, Cheshire, UK
Homerton University Hospital, London, UK
Homerton University Hospital, London, UK
University of Sheffield, Sheffield, UK

Unknown speaker

Leighton Hospital, Cheshire, UK
Homerton University Hospital, London, UK
Homerton University Hospital, London, UK
University of Sheffield, Sheffield, UK
University of Birmingham, Birmingham, UK
Mid Cheshire Hospitals NHS Foundation Trust
Homerton University Hospital, London, UK
Homerton University Hospital, London, UK
University of Sheffield, Sheffield, UK
Wed 10 09:35
Clinical Skills: Genetics for the Endocrinologist
Kilsyth & Moorfoot
Chairs: Dr Miles Levy (The University Hospital of Leicester, Leicester, UK) & Dr Sinéad McGlacken-Byrne (UCL Great Ormond Street Institute of Child Health, London, UK)
Wed 10 09:35
SK1.1
Clinical Skills: Genetics for the Endocrinologist
The Geneticist's Perspective
Department of Clinical Genetics, Guy's and St Thomas' NHS Foundation Trust, London , UK
Wed 10 09:55
SK1.2
Clinical Skills: Genetics for the Endocrinologist
The Endocrinologist's Perspective
University of Dundee, Dundee, United Kingdom
Wed 10 09:35
Basic Skills: Grants and Teaching
Sidlaw Auditorium
Chairs: Dr Karen Forbes (University of Leeds, Leeds, UK) & Mariana Norton (Imperial College London, London, UK)
Wed 10 09:35
SK2.1
Basic Skills: Grants and Teaching
Grants
University of Aberdeen, Aberdeen, UK
Wed 10 09:55
SK2.2
Basic Skills: Grants and Teaching
Teaching
Imperial College London, London, UK
Wed 10 13:05
INDUSTRY-SPONSORED SATELLITE SYMPOSIA - (Please see Sponsored Satellite Symposia programme for more information)
Kilsyth & Moorfoot
Wed 10 13:05
INDUSTRY-SPONSORED SATELLITE SYMPOSIA - (Please see Sponsored Satellite Symposia programme for more information)
Sidlaw Auditorium
Wed 10 14:10
Endocrine Network Session 1 - Adrenal and Cardiovascular
Endocrinology, Diabetes & Metabolism Case Reports
Carrick 1
Chairs: Dr Miles Levy (University Hospitals of Leicester, Leicester, UK) & Dr Scott Mackenzie (University of Glasgow, Glasgow, UK)
Wed 10 14:10
Endocrine Network Session 1 - Adrenal and Cardiovascular
Vaccine-Induced Adrenal Haemorrhage
University Hospital of Wales, Cardiff, UK
Wed 10 14:10
Endocrine Network Session 2 - Bone and Calcium
Parathyroid UK
Carrick 2
Chairs: Professor Jeremy Turner (Norfolk and Norwich University Hospitals NHS Foundation Trust, Norwich, UK) & Dr Caroline Gorvin (University of Birmingham, Birmingham, UK)
Wed 10 14:10
Endocrine Network Session 2 - Bone and Calcium
Updates and future plans for the Bone and Calcium network
Norfolk and Norwich University Hospital, Norfolk, UK
University of Birmingham, Birmingham, UK
Wed 10 14:10
Endocrine Network Session 3 - Endocrine Consequences of Living with and beyond Cancer
Endocrine-Related Cancer
Ochil 1
Chairs: Dr Helen Simpson (University College London Hospital, London, UK) & Claire Higham (The Christie NHS Foundation Trust, Manchester, UK)
Wed 10 14:10
Endocrine Network Session 3 - Endocrine Consequences of Living with and beyond Cancer
Updates and future plans for the Endocrine Consequences of Living with and beyond Cancer network
Wed 10 14:10
Endocrine Network Session 4 - Endocrine Cancer
Endocrine Oncology
Sidlaw Auditorium
Chair: Kate Lines (University of Oxford, Oxford, UK)
Wed 10 14:10
Endocrine Network Session 4 - Endocrine Cancer
Hormones, Cancer and COVID - headlines from 2020-21
Imperial College London, London, UK
Wed 10 14:10
Endocrine Network Session 4 - Endocrine Cancer
A survey on the management of metastatic PPGL in UK & Ireland

Unknown speaker

Cambridge University Hospital NHS Foundation Trust, Cambridge, United Kingdom
Wed 10 14:10
Endocrine Network Session 5 - Metabolism, Obesity and Diabetes
Endocrinology, Diabetes & Metabolism Case Reports
Ochil Suite 2 & 3
Chair: Dr Gavin Bewick (King’s College London, London, UK)
Wed 10 14:10
Endocrine Network Session 5 - Metabolism, Obesity and Diabetes
What skills, techniques and experience can you gain from visiting another laboratory
Coventry University, Coventry, UK
Wed 10 14:10
Endocrine Network Session 6 - Neuroendocrinology
Journal of Endocrinology
Carrick 3
Chair: Dr Niki Karavitaki (University of Birmingham, Birmingham, UK)
Wed 10 14:10
Endocrine Network Session 6 - Neuroendocrinology
Discussion of audits and research and plans for the Network
Birmingham, UK
Wed 10 14:15
Endocrine Network Session 6 - Neuroendocrinology
How to follow-up a patient with with Cushing's and remission after surgery
University of Sheffield, Sheffield, UK
Wed 10 14:10
Endocrine Network Session 7 - Reproductive Endocrinology and Biology
Journal of Molecular Endocrinology
Tinto
Chairs: Professor Colin Duncan (The University of Edinburgh, Edinburgh, UK) & Dr Kim Jonas (King’s College London, London, UK)
Wed 10 14:10
Endocrine Network Session 7 - Reproductive Endocrinology and Biology
Fertility and its preservation in the transgender population
Edinburgh, UK
Wed 10 14:10
Endocrine Network Session 8 - Thyroid
Clinical Endocrinology
Kilsyth & Moorfoot
Chairs: Professor Peter Taylor (Cardiff University, Cardiff, UK) & Fraser Gibb (Edinburgh Centre for Endocrinology and Diabetes, Edinburgh, UK)
Wed 10 14:10
Endocrine Network Session 8 - Thyroid
An overview of thyroid papers
University of Edinburgh, Edinburgh, UK

Unknown speaker

University of Edinburgh, Edinburgh, UK
Cardiff University, Cardiff, UK
Wed 10 14:20
Endocrine Network Session 8 - Thyroid
Summary of the NIHR assessment of RFA in thyroid nodules
University of Birmingham, Birmingham, UK
Wed 10 14:30
Endocrine Network Session 8 - Thyroid
Updates and future plans for the Thyroid network
Wed 10 14:50
Early Careers Session
Sidlaw Auditorium
Chairs: Jolyon Dales (University Hospitals Leicester NHS Trust, Leicester, UK) & Mariana Norton (Imperial College London, London, UK)
Wed 10 14:50
Early Careers Session
An insight into a venture capital career
The University of Edinburgh, Edinburgh, UK
Wed 10 15:05
ECS1.2
Early Careers Session
Post-doc to Research Facilitator; making the transition
University of Birmingham, Birmingham, UK
Wed 10 15:20
Early Careers Session
Influencing at scale: NHS leadership and shaping policy
University Hospitals Birmingham, Birmingham, UK
Wed 10 15:35
Early Careers Session
Clinical teaching careers
Imperial College London, London, UK
Wed 10 15:50
Early Careers Session
University research & teaching careers
Imperial College, London, UK
Wed 10 14:50
Cutting Edge - Use and Abuse Endocrinology: Enhancing Performance At Any Cost?
Endocrine Connections
Pentland Auditorium
Chairs: Dr Helen Turner (Oxford University Hospitals NHS Foundation Trust, Oxford, UK) & Dr Jonathan Hazlehurst (University of Birmingham, Birmingham, UK)
Wed 10 14:50
Cutting Edge - Use and Abuse Endocrinology: Enhancing Performance At Any Cost?
Adverse effects of anabolic steroid use
Harvard Medical School, Boston, USA
Wed 10 15:15
Cutting Edge - Use and Abuse Endocrinology: Enhancing Performance At Any Cost?
GH as a performance enhancing drug
University of Southampton, Southampton, UK
Wed 10 15:40
Cutting Edge - Use and Abuse Endocrinology: Enhancing Performance At Any Cost?
Blood doping: climbing to the peak of athletic performance
Oslo University Hospital, Oslo, Norway
Wed 10 17:20
Close of Conference
Pentland Auditorium

0 result(s) found.

Please wait...

     
      - 
     
     
     


    Abstracts from this event
      Abstracts from other events


          Session starts at:
          Abstract time:
        Event:


        Read full abstract